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A BST R A C T

Phage display is a powerful and versatile technology that enables the selection of
novel binding functions from large populations of randomly generated peptide sequences.
Random sequences are genetically fused to a viral structural protein to produce complex
peptide libraries. From a sufficiently complex library, phage bearing peptides with
practically any desired binding activity can be physically isolated by affinity selection,
and, since each particle carries in its genome the genetic information for its own
replication, the selectants can be amplified by infection of bacteria. For certain
applications however, existing phage display platforms have limitations. One such area is
in the field of vaccine development, where the goal is to identify relevant epitopes by
affinity-selection against an antibody target, and then to utilize them as immunogens to
elicit a desired antibody response. Today, affinity selection is usually conducted using
display on filamentous phages like M13. This technology provides an efficient means for
epitope identification, but, because filamentous phages do not display peptides in the
high-density, multivalent arrays the immune system prefers to recognize, they generally
iv

make poor immunogens and are typically useless as vaccines. This makes it necessary to
confer immunogenicity by conjugating synthetic versions of the peptides to more
immunogenic carriers. Unfortunately, when introduced into these new structural
environments, the epitopes often fail to elicit relevant antibody responses. Thus, it would
be advantageous to combine the epitope selection and immunogen functions into a single
platform where the structural constraints present during affinity selection can be
preserved during immunization.
This dissertation describes efforts to develop a peptide display system based on
the virus-like particles (VLPs) of bacteriophage MS2. Phage display technologies rely on
(1) the identification of a site in a viral structural protein that is present on the surface of
the virus particle and can accept foreign sequence insertions without disruption of protein
folding and viral particle assembly, and (2) on the encapsidation of nucleic acid
sequences encoding both the VLP and the peptide it displays. The experiments described
here are aimed at satisfying the first of these two requirements by engineering efficient
peptide display at two different sites in MS2 coat protein. First, we evaluated the
suitability of the N-terminus of MS2 coat for peptide insertions. It was observed that
random N-terminal 10-mer fusions generally disrupted protein folding and VLP
assembly, but by bracketing the foreign sequences with certain specific dipeptides, these
defects could be suppressed. Next, the suitability of a coat protein surface loop for
foreign sequence insertion was tested. Specifically, random sequence peptides were
inserted into the N-terminal-most AB-loop of a coat protein single-chain dimer. Again we
found that efficient display required the presence of appropriate dipeptides bracketing the
peptide insertion. Finally, it was shown that an N-terminal fusion that tended to interfere
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specifically with capsid assembly could be efficiently incorporated into mosaic particles
when co-expressed with wild-type coat protein.
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INTRODUC TI ON
H istory
Initially described by George Smith in 1985, phage display represents a method
for the presentation of peptides or proteins on the surfaces of virus particles. Essentially,
SHSWLGHVDUH³GLVSOD\HG´E\IXVLQJQXFOHRWLGHVHQFRGLQJWKHJHQRPLFLQIRUPDWLRQRIWKH
target peptide to genomic regions coding for coat protein of phage. Using recombinant
DNA techniques, foreign sequences are joined to a gene encoding a coat protein, thereby
creating a fusion protein [1]. These recombinant proteins are then incorporated into
newly forming phage particles preparing for final release from the host cell. Libraries of
phage particles are created when a mixture of recombinant sequences are utilized to
produce phage clones each carrying a unique recombinant sequence.
Presently, numerous libraries of phage displaying peptides, antibodies, or other
bio-molecules have been constructed and many are now being screened for the ability to
bind to specific ligands. Each recombinant phage genome contains the DNA sequence
encoding the peptide or protein displayed on its surface. This means that phages
displaying peptides with a particular binding function (e.g. affinity for a monoclonal
antibody) can be physically purified from a complex random sequence library and then
amplified by simple infection of E. coli. It should be noted that filamentous phage
display, and other related technologies, rely on two essential features: (i) the ability to
display a foreign peptide in a biochemically accessible form, and (ii) a physical linkage
of the displayed peptide or protein to the nucleic acid that encodes it.
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F ilamentous Phage Display
Although several different bacteriophages have been utilized for this purpose,
display systems based on filamentous phage dominate the scientific landscape. The most
commonly used are based on f1, fd, and M13 phages. As figure 1 depicts, several coat
proteins are present in the final phage particle. Coat protein pVIII predominates and is
frequently a target for display. However, other coat proteins including pIII and pVI are
also utilized.
T he L ife C ycle of Filamentous Phage
The life cycle of filamentous phage is schematically presented in Figure 2 [2].
Infection starts as pIII attaches at the F pilus of Escherichia coli . The pilus then pulls in
towards the cell until the pIII protein of phage particle is able to interface directly with
the cellular boundary. Next, in a poorly understood process, the phage particle then
begins to disassemble and transfer of the viral genome occurs. Once the viral genome is
in the cell, it is converted into double stranded DNA (dsDNA). The genome is then
amplified in preparation for mature viral particle assembly.
As genomic amplification occurs, viral proteins also begin to appear in the cell.
Several of these viral proteins are targeted for export into the periplasm in preparation for
final assembly of the mature particle. The viral particle is assembled at the cell membrane
and is extruded from it while the cell itself remains intact. Of course, it is precisely these
viral structural porteins that are the targets for foreign peptide insertion in phage display.
Some peptides possess amino acid sequences incapable of traversing the host cell wall.
This inability to traverse the cellular membrane relates to the characteristics of some
amino acids (i.e hydrophobicity). As a result, some recombinant phage particles never
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exit the host cell and are not represented in the final recombinant phage library
population. This resulting loss of library sequence complexity is sometimes called
library censorship.

F igure 1. A view of M13 filamentous phage
The structure of M13 is similar to the structure of other filamentous phage particles. The
particle is approximately 1 m in length and about 6 nm in diameter. The major coat
protein, pVIII, encircles the genome encoding the particle and has been a target for phage
display. At the temini of the phage particle, pIII, represents another frequent target for
phage display applications. Reprinted with permission [3].
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F igure 2. A view of M13 filamentous phage assembly
A critical aspect to M13 phage assembly is that it occurs in the periplasmic space in
between the inner and outer membrane of the host cell. As the diagram depicts, however,
some questions remains on how M13 is able to complete the highly complex and
orchestrated process of cellular exit. Viral particle exit occurs without killing the host
cell and is often described as a parasitic process. Reprinted with permission [2].
A lternative Phage Display Systems
As a result of library censorship and other limitations of the filamentous phage
display system, efforts have focused on other bacteriophages for display applications. Of
note, have been recent intensive efforts to bring lytic phages online for phage display.
Lytic phage systems offer an advantage in that proteins associated with capsids are
assembled and folded in the cytoplasm, thus avoiding avoiding constraints imposed by
the secretory process filamentous phages utilize to generate phage particles [1]. Presently
three prominent lytic phage systems have been identified for display applications. These
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SODWIRUPVLQFOXGH77DQGȜ+RZHYHUWKHVHQHZGLVSOD\V\VWHPVKDYHOLPLtations of
their own [4]. For example, T4 does not yet have an efficient in-vitro packaging system,
and thus limits its usefulness in larger peptide display libraries [4]. In T7, it has already
been demonstrated that some small proteins are refractory to high copy number display
[4]. In WKHFDVHRIȜFDSVLGDVVHPEO\LQYROYHVWZRSURPLQHQWSURWHLQVDQGWDNHVVHYHUDO
steps to complete the phage construction process ± which may hinder efficient packaging
and display of foreign peptides. In any case, all these systems are based on complex
viruses whose replication and morphogenesis require infection of intact cells. This point
is made because other display activities, not based on bacteriophages, have already
moved away from intact cells to cell-free systems in an effort to increase library diversity
and to potentially address concerns related to library censorship, cellular toxicity, etc [5].
Peptide Presentation Systems Not Based on Phages

Ribosome Display
Ribosome display offers a unique approach to peptide display [6-8]. Libraries of
random peptide or protein sequences, usually linked by recombinant DNA methods to a
carrier protein, are expressed in cell-free protein synthesis systems derived from an
appropriate organism (e.g. E. coli, wheat germ, rabbit reticulocytes, etc). Thus, even
proteins toxic to the hosts in which they are normally expressed can be collected and
subjected to analysis. Ribosome display extends cell-free expression by linking newly
expressed proteins to the mRNA template from which they were expressed (Figure 3).
And these complexes of protein, ribosome, and mRNA are subjected to affinity selection.
The linkage of foreign sequences to the mRNA that encodes them ensures that selected
sequences can be recovered and amplified [7, 8].
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Peptide Display using mRN A
An offshoot of ribosome display is mRNA display (Figure 3, bottom panel). In
this system, peptides in the library become covalently fused to the mRNA strand that
encodes them. Briefly, mRNA display starts with a library of DNA. The library is then
transcribed into mRNA -with these transcripts becoming fused to a DNA linker. This
DNA linker also contains a puromycin moiety. As the mRNA is translated in-vitro, the
ribosome proceeds until it encounters the RNA-DNA boundary, where it stalls. It is at
this point that the puromycin moiety binds at the A site of the ribosome. This action then
allows for the generated peptide to become transferred to the puromycin moiety and
released from the ribosome. This new complex of mRNA and protein is then used for
subsequent peptide display processing.

Peptide Display on H epadnavirus-Like Particles
The approaches described above all have the ability exploit affinity selection as a
means of identifying peptides with desired binding activities. Sometimes, however, it is
sufficient simply to display a known peptide sequence previously identified by other
means. For example, peptides are sometimes displayed on virus-like particles (or VLPs)
as a means of conferring to them a high degree of immunogenicity, thus making them
potentially useful as vaccines. Billaud et al. have inserted foreign peptides into various
surface-exposed sites on hepadnavirus core protein VLPs [9]. However, it is frequently
observed that such insertions disrupt the ability of the viral protein to properly fold. To
accommodate a wide variety of different peptide inserts, this group found it necessary to
LGHQWLI\DQ³RSWLPDOFRPELQDWLRQ´RILQVHUWLRQVLWHFRXSOHGZLWKRWKHUVWDELOL]LQJ
modifications to allow for maximum incorporation of foreign sequences. They showed
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that flanking acidic amino acid brackets around a recombinant sequence stabilized
insertions and allowed for virus-like particle assembly. However, optimal insertion
position, insert sequence, and C-terminal modification were also required. This approach
has served well for generating virus-like particles displaying a variety of peptides, but the
method is laborious, since each peptide can require an unpredictable combination of
insertion site and C-terminal modification. Furthermore, the lack of an affinity selection
capability makes this system unsuited to epitope identification by affinity selection
against antibody targets. The work described below was motivated by a desire to develop
a phage display platform combining the potent immunogenicity of the VLP with the
affinity selection capabilities of existing phage display systems.
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F igure 3. A view of ribosome and mR N A display
The top panel highlights ribosome display. In this system, a DNA library encompassing
proteins of interest is first linked to a spacer sequence that has no stop codon. This new
DNA hybrid is then transcribed into an mRNA complex ready for ribosomal docking and
translation. As the ribosome translates the resultant mRNA, it encounters the spacer
sequence and stalls. At this point, translation is terminated and the resulting complex of
bound ribosome, mRNA, and protein become available for subsequent peptide display
applications. In the bottom panel, a system is described for mRNA display. In this
system the ribosome is ultimately released. In this system, the library of DNA is
transcribed in-vitro, and the resulting mRNAs becomes available for further processing.
The library of mRNA transcripts is fused to a DNA linker that carries puromycin. As the
ribosome proceeds with translation, it reaches the RNA-DNA boundary and stalls. The
puromycin moiety is then able to complex with the ribosome at the A site, where the
peptide is transferred to the puromycin moiety. This final step causes ribosomal release
resulting in a complex containing the mRNA (genotype) covalently linked to resulting
protein (phenotype) via a puromycin linker. Reproduced with permission [10].
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Bacteriophage MS2: A New Phage Display Platform
The efforts described in this dissertation focused on the development of a peptide
display system based on VLPs of bacteriophage MS2 (Figure 4), a small (+)-sense,
single-stranded RNA virus with a geonome consisting of only 3,569 nucleotides. The
icosahedral shell of the viral particle is made up of a single coat protein, which, in
addition to its structural role, acts as translational repressor of viral replicase synthesis.
As we will see, it is 
'
,
(*
',

"
&9+,
*
&+$,"
'&
$*

(ressor activity that is of significant
interest for a new phage display system. As manipulation of the coat protein for display
applications requires the insertion of peptides, it is anticipated that non-functional coat
proteins will easily be identified as non-functional repressors and quickly be excluded
from analysis as the operational parameters of a display system based on MS2 are
established.

F igure 4. A V iew of MS2
A view of the capsid produced by MS2. The genome of bacteriophage MS2
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E ngineering Advantages of MS2
As bacteriophage MS2 VLPs were being evaluated for phage display applications,
several advantages were quickly identified. First, MS2 consists only of a single coat
protein. Filamentous phage, on the other hand, employs several coat proteins to achieve
final particle assembly. In the case of MS2, it is expected that by having only one coat
gene to manipulate that problems routinely encountered during peptide insertion will be
easier to identify and correct. Second, MS2 coat protein readily self-assembles into
capsids of icosahedral geometry. Coat protein alone is sufficient ± i.e. no other viral
components are required for assembly and coat protein expressed from a plasmid
efficiently produces virus-like particles [11]. Importantly, MS2 VLPs package the
mRNA that encodes them, thus providing the linkage between the phenotype and
genotype required for amplification of affinity selected sequences.
Because of the structural simplicity of the MS2 VLP, it should be possible to
produce the particles in vitro by coupled transcription/translation. Due to constraints
imposed by the need to propagate other phage display vehicles in bacteria, the practical
upper limit on peptide library complexity is thought to be around 1010-1011. However, if
VLP synthesis and assembly could be made to occur in vitro, growth in E. coli would be
unnecessary and the numerical advantages inherent in working with molecules instead of
cells, would become manifest. The first requirement of a display system based on MS2
VLPs is the identification of sites in coat protein that both tolerate the insertion of foreign
peptide sequences and present the peptide in accessible form at the VLP surface. In a
nutshell, this is the purpose of the work described here.
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Proposed Insertion Sites for MS2 Display
A first step in developing bacteriophage MS2 for display applications was to
identify sites in the coat protein that accepted foreign peptides and presented them at the
capsid surface. Inspection of the coat protein's structure revealed two obvious candidates,
the AB-loop, a short sequence connecting two ß-strands of coat protein on the surface of
the viral particle, and the N-terminus. The AB-loop has already been employed for the
engineered presentation of a few specific peptides [11-13]. Additionally, limited work
has been performed to suggest that the N-terminus may also be a viable target for display
applications [11]. To determine the utility of the AB-loop and N-terminus for peptide
presentation, we proposed to create a library of peptide insertions and determine the
fraction of recombinants that retained function. It was anticipated that these peptide
insertions, as in other systems, would lead to non-viable phage virus-like particles. These
deficiencies have occurred either because of a failure of the capsid protein to properly
fold, or because to folded recombinant coat protein failed to assemble into a VLP. This
dissertation describes efforts to accomplish peptide display on MS2 VLPs and has the
following aims:
Specific A im #1: To determine the tolerance of the AB-loop to peptide insertions

generally, and assess the potential use of single-chain dimers to allow for greater peptide
library diversity.
Specific A im #2: To determine the tolerance of the N-terminus to peptide

insertions generally, and assess the potential use of single-chain di mers to allow for
greater peptide library diversity.
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Prior Work on MS2 VLP Display
A great deal of effort has been devoted to understanding the RNA recognition
properties of coat protein. During those studies two technical tools were devised that have
special relevance to the present work [14]. First, since coat protein is a translational
repressor of replicase synthesis it was possible to construct a two-plasmid system in
which coat protein expressed from one plasmid represses the translation of a replicase-ßgalactosidase fusion protein expressed from a second plasmid. Thus bacteria expressing a
functional repressor give white colonies on plates containing the chromogenic substrate
x-gal, while repressor defects yield blue colonies. In the present work this translational
repression assay provided a convenient means of determining whether a peptide insertion
inactivated coat protein by disrupting folding. Second, a convenient electrophoretic assay
was devised that permits the facile determination of the presence of VLPs in crude lysates
of coat protein expressing cells.
Preliminary efforts to display peptides on MS2 VLPs were described by Peabody,
who showed that insertion of the so-called Flag peptide in the AB-loop of MS2 coat
protein resulted in a failure of the protein to properly fold [11]. However, this folding
failure could be suppressed in coat protein single-chain dimers, a modified form of coat
protein in which the two identical chains of the coat dimer are fused into a single
polypeptide chain. Subunit fusion increases the thermodynamic stability of the protein
and greatly increases its tolerance of amino acid substitutions, peptide insertions and
chemical denaturants. The presence of the Flag peptide in the AB-loop was tolerated as
long as it was restricted to one of the two halves of the single-chain dimer. In the same
work, Peabody described the display of the Flag peptide by fusion to the coat protein N-
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terminus, and showed that although the presence of the peptide did not interfere with
protein folding (as assessed by the translational repression assay), assembly of the VLP
required the use of the single-chain dimer. Presumably the presence of Flag caused
molecular crowding a local 3-fold symmetry axes. Of course the single-chain dimer has
only half as many N-termini as the wild-type protein, so crowding was sufficiently
reduced to allow VLP assembly. Finally, a more comprehensive study conducted by
Peabody et al., showed that the vast majority of random sequence insertions into the ABloop of the downstream half of the single-chain dimer was well tolerated as assessed by
retention of translational repressor activity and the ability to produce a VLP [12]. This
body of prior work provided a model for the experimental approaches taken in the work
described in this dissertation.

Characterize Recombinant F olding via Translation Repression Assay
In order to characterize the functional behavior of recombinant proteins, a
translational repression assay was first performed. This assay takes advantage of a
unique functional feature associated with MS2 coat protein. Under normal conditions,
the coat protein of MS2 acts to repress translation by inhibiting the synthesis of viral
replicase. MS2 coat protein, as it dimerizes, is able to achieve this by binding to the
translational operator region (i.e. ribosome-binding site) of replicase. As described in a
study by Peabody, the region encompassing the translational operator of replicase can be
fused to the E.coli lacZ gene to form a replicase-ȕ-galactosidase fusion protein[14]. This
fusion protein, as demonstrated in the same study by Peabody, is then capable of being
modulated by the production and interaction with wild-type MS2 coat protein. The lacZ
gene, which is part of the lac operon, allows for the synWKHVLVRIȕ-galactosidase. On
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indicator plates that contain 5-bromo-4-chloro-indolyl-ȕ-D-galactosidase (X-JDO ȕgalactosidase cleaves X-gal producing a characteristic blue color. In this same study by
Peabody, the replicase-ȕ-galactosidase fusion construct was placed into a separate
plasmid and then stably transformed with a plasmid containing the MS2 coat sequence
under study. The results demonstrated that by employing a two-plasmid system whereby
coat protein generated on one plasmid repressed the prodXFWLRQRIȕ-galactosidase on
another plasmid, MS2 coat protein function could readily be assessed. Thus, this study
established a link between the ability of MS2 coat protein to repress translation and its
inherent folding behavior. In the present study, a similar repression assay was utilized.

Characterize Recombinants by Restriction Digest
The next step in the experimental process was to verify whether or not
recombinants were being generated in the newly synthesized libraries. From each library,
a number of individual white and blue colonies were be selected and picked to two 1 ml
cultures in LB medium and grown overnight with agitation at 37° C. One set of cultures
was then used to isolate the recombinant plasmid via mini-prep methodology. In this
case, once the plasmids were obtained, those same restriction endonucleases used to
insert the original peptides fragments were used to generate new fragments from the
library and compared against restriction fragments generated by parental plasmids that
contain unmodified coat sequences. Digested fragments were then subjected to gel
electrophoresis and characterized. Those fragments that were recombinant had a greater
size than those generated from parental plasmids. From those colonies that were deemed
to be recombinant, an additional step of DNA sequence analysis was performed.
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Virus-Like Particle (VLP) F ormation Assay
A key outcome of this experimental effort was the expectation that the
introduction of peptides into the coat of MS2 would not prevent VLP assembly. To
monitor VLP formation, individual white or blue clones were selected from each
experimental variation and subjected to analysis. First, sonicated cell lysates from
individual clones were collected and then subjected to agarose gel electrophoresis. Next,
these lysates were visualized via an indirect method by which gels were stained with
ethidium bromide. This step was critical in that ethidium bromide intercalates with the
nucleic acid normally encapsidated by properly formed virus-like particles. Although not
definitive, ethidium bromide staining provided the first indication that VLPs
incorporating N-terminal extensions were being formed.
Once completed, ethidium bromide staining was then contrasted with Western
blot analysis to firmly establish the presence or absence of MS2 VLPs. Western blot
analysis was accomplished by staining a blot with anti-MS2 serum, followed by a
resolution step involving the application of alkaline phosphatase-conjugated anti-rabbit
IgG. As recombinant MS2 VLPs are inherently made up different amino acids, the
mobilities associated with amino acids served to further establish the presence of unique
recombinant VLPs. Thus, this assay provided insight into VLP formation.
To test the hypothesis that MS2 could act as a suitable platform to generate
peptide libraries, we then initially investigated insertions at the N-terminus and in the
AB-loop of the MS2 coat protein. Expecting that these insertions would be highly
disruptive to VLP formation, we added an additional element in which we would
introduce the use of a single chain fused dimer of MS2 coat protein to potentially
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stabilize any aberrant protein recombinants[11]. Figure 5 illustrates the nature of the
insertions made.

F igure 5. T emplates for construction of MS2 libraries
Recombinant libraries were generated in the monomeric and dimeric forms of MS2 coat
protein. Insertions were made at the N-terminus and AB-loop of the coat gene and
recombinants were subsequently obtained. The nature of these insertions was randomly
generated 30 nucleotide sequences. These sequences were generated using primers of the
(NNY)10 replicated motif respectively - where N = A,C,G, or T; Y= T or C. Use of these
primers allowed for the generation of 15 amino acids without the inclusion of any stop
codons. Amino acids not produced utilizing this primer motif were Lys, Glu, Gln, Trp,
and Met. This approach was undertaken to allow for rapid initial assessment of
recombinants.

Recombinant sequences were then generated based on the proposed scheme for
peptide insertion and transformed into a laboratory strain of e-coli and plated on nutrient
rich agar to generate coat protein. Utilizing the aforementioned repression assay, colonies
were then segregated based on their implied ability to fold properly into dimers and then
subjected to sequence analysis. After obtaining sequence information, only those
recombinants with proper sequence structure (i.e no frameshifts, stop mutations, etc.)
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were included in subsequent analysis. Table I highlights the results of these initial
experiments.
Insertions into the monomer of MS2 produced very few white colonies ±
suggesting that these insertions were highly disruptive at both the N-terminus and ABloop. However, we also generated recombinants into a single-chain fused dimer of the
MS2 coat protein. The results of these dimer experiments are also shown in Table I. In
the case of 30 nucleotide or 10 amino acid insertions, modifications to AB-loops
benefitted from the implementation of the single-FKDLQGLPHU,QVHUWLRQVLQWRWKH¶
downstream loop showed greater than 90 % fold competence. However, the results for
WKH¶XSVWUHDPKDOIRIWKHGLPHUZHUHVWLOOGLVFRXUDJLQJ:LWKIROGFRPSHWHQFHQHDU
40% for WKH¶$%-loop, it was assumed that the experimental design had introduced
some anomaly into the effort and the construction of recombinants and subsequent
analysis was repeated. However, at the end of this new effort, the initial results were
confirmed aQGLWDSSHDUHGWKDWRQO\WKH¶ORRSRIWKHVLQJOH-chain dimer would be viable
in any future phage display efforts. In the case of N-terminus, insertions into the
monomer and dimer of MS2 demonstrated that the n-terminus was almost entirely
refractory to proper folding in both test conditions. This result was unexpected given that
previous work had shown that peptides insertions were possible at the N-terminus of
MS2, and that the single-chain dimer was a beneficial addition[11].
As part of this study by Peabody, the Flag peptide was inserted at the N-terminus
of MS2. It was expected that the Flag peptide could be expressed in a VLP, and that a
commercially available antibody would detect the presence of Flag. Experimental data
showed that Flag incorporation did not impact the ability of MS2 coat to fold. However,
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the Flag coat fusion did fail to assemble into a VLP. To correct for this assembly defect,
two coat protein monomers were fused into a single-chain dimer and the Flag peptide was
re-incorporated. In this new configuration, the Flag peptide was shown to properly fold
and assemble into a VLP.
During preliminary experiments for this new effort, however, the n-terminus
appeared refractory to random insertions even with the additional use of the single-chain
dimer. It was at this point that a key observation was made. N-terminal insertions, in
general, were highly destabilizing, and that future attempts would likely require extensive
engineering of the recombinant insert to produce viable proteins.

T able I. Preliminary translation repression results
Translational repression as express by colony color provides insight into ability of
recombinant protein to fold. Recombinant libraries were generated in the monomeric and
dimeric forms of the MS2 coat protein. Insertions were made at the AB-loop or Nterminus of the coat gene and recombinants were subsequently obtained. The nature of
these insertions was 30 nucleotide (10 amino acid) sequences.
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A NE W DIRE C TI ON
Given the inability of bacteriophage MS2 to effectively tolerate insertions at the
N-WHUPLQXVDQGLQWKH¶$%-loop, the focus of this effort quickly shifted to explore the
potential nature of the peptide insertions themselves. Length of insert, volume of insert,
hydrophobicity, and relative isoelectric point were suggested as key determinants
influencing peptide behavior in preliminary literature reviews. However, a deeper review
of research extending back thirty years suggested that peptide behavior in the context of a
phage display system may be a much more complex problem. After a more detailed
review of relevant research on peptide insertion, de novo protein synthesis, and general
aspects of protein folding, five novel approaches emerged in relation to the display of
foreign peptides. These five ideas are listed as follows:
x

Masking the nature of peptide insertions

x

Amino acid propensities in the context of secondary structures

x

Stereochemical initiation/termination of secondary structures

x

Exploitation of cellular processes that enhance folding

x

Helper proteins in mosaic capsid formation

Each of these approaches encompassed an expanded approach to allow for the
accommodation of foreign peptides at the N-terminus and AB-loop of bacteriophage
MS2. Background on each approach follows in the next sections. As a result of this
revised, expanded effort, the final specific aims for this peptide display study were
expanded to include on additional theme. The final theme centered on several targeted
approaches was devised to specifically address N-terminal insertions. Results from all
experimental efforts are detailed later in this study.
19

  
M asking the E ffects of Peptide Insertions
Peptide insertions in the AB-loop and N-terminus of bacteriophage MS2 have
proven to be highly destabilizing. Ballaud et al. were faced with a similar problem in
their attepmtps to display foreign peptides on hepadnaviral VLPs. Basically, this group
PDGHWKHREVHUYDWLRQWKDWWKH³RSWLPDOFRPELQDWLRQ´RILQVHUWLRQVLWHFRXSOHGZLWh
stabilizing modifications could allow for maximum incorporation of foreign sequences
[9]. Along with this observation, was a key finding that the charge of the foreign
sequence appeared to greatly influence whether or not peptide incorporation and
successful virus-like particle assembly was achieved. As the group continued to refine
their combinatorial approach, it was noted that the increased presence of highly basic
amino acids correlated with the inability of hepadnavirus-like particles to assemble [9].
Additionally, as more data was accumulated, a theme emerged that suggested that the
isoelectric point of the target foreign sequence also correlated with particle assembly [9].
These findings were significant in that the final experiments described in this study
employed the use of flanking acidic amino acid brackets to revert assembly defects
observed with peptides that had high net positive charge (high pI) [9]. However, optimal
insertion position, insert sequence, and C-terminal modification were also required to
effectively allow for peptide insertion in this hepadnavirus model. Yet, this idea of being
DEOHWRLQIOXHQFHFKDUJHFRXOGSURYLGHWKHLPSHWXVWRWU\DQG³HQJLQHHU´SHSWides prior to
insertion at the N-terminus of MS2 to revert folding and assembly defects encountered in
our preliminary experiments. Although the efforts of this study suggested a rational
approach to increase successful peptide incorporation, other factors including
hydrophobicity, high E-strand index, insertion length, etc., also required consideration
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[9]. With this notion in mind, literature reviews identified other opportunities to
potentially aid in the display of peptides.
A mino A cid Propensities in the Context of Secondary Structures
Amino acid sequences carry key structural information for native proteins as they
fold into their final conformations. Although this concept is not new, it offers a
fundamental premise that must be considered when attempting to insert foreign
sequences into virus-like particles. As the literature suggests, considerable effort has been
expended to link an amino acid sequence to a propensity to form a defined secondary
structure [15-20]. In a hallmark paper, an innovative predictive model was established in
which amino acid sequences prompted the development of secondary structure [18]. In
this study, crystallographic data was employed to establish amino acid preferences for Esheet, random coil, and helical regions for 15 proteins. Amino acids were classified as
residues in helix, residues in inner helix, residues in E region, or residues in coil region.
Concurrent to this effort, a far-reaching mechanism was proposed that posited helix and
beta nucleation originated centrally in their respective structures and spread bidirectionally until strong terminal residues were encountered [18, 19]. As a result, rules
established from this study allowed for the generation of an early model to predict
secondary structure from an amino acid sequence [19]. With this in mind, Chou and
Fasman became one the first groups to establish conformational parameters or what
others call propensities for secondary structures.
In another foundational study, preferences were noted for amino acids throughout
the span of a D-helix and also at positions close to its termini. This study conducted by
Richardson and Richardson differed from the one presented by Chou and Fasman in that
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amino acid propensities were identified specifically for positions throughout a helix as
RSSRVHGWR³JHQHUDO´VHFRQGDU\VWUXFWXUHUHJLRQV LHLQQHU, terminal region, etc.).
Essentially, Richardson and Richardson identified for the first time position-specific
preferences for amino acids in helices ± which could provide benefit in reverting MS2
fold defects encountered in the N-terminus. In this study, 215 helices were compiled into
a database so that statistically significant single-position helix preferences were
established for helices [15]. Additionally, a new concept was defined as part of this effort
in which N- and C-helix terminal residues became defined as capping residues. This
concept was significant in that the N-cap or C-cap residues, which by definition are
residues half in and half out of a helix, represented true terminal boundaries in secondary
structures [15]. This ability to identify an amino acid at the helix interface was an
outgrowth of a prevalent theory that helix boundaries could be defined by D-carbon
positions. More concisely, cap residues in a helix could be defined as the first (N-cap) or
last (C-cap) amino acid whose D-carbons reside in a cylinder formed by the spiral
structural backbone of a helix [15]. Prior to this assertion, three theories dominated
formation of helix boundaries. One defined these boundaries by I and \ angles, while
the other two looked at hydrogen bonding and D-carbon positions [15]. In this study by
Richardson and Richardson, each of these theories was tested ± with the D-carbon theory
emerging as being more likely. Once this definition for a helical boundary was
established, Richardson and Richardson identified Gly as having a strong C-cap
preference and Ser as having a strong N-cap preference. In both cap instances, other
researchers reported similar findings, so the theory and inferences made from D-carbon
position appeared to be reinforced. Additionally, Asn, Gly, Thr and Asp were identified
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as also having strong N-cap preference. Ser, Asn, Lys, Ala, and Leu emerged as having
the highest propensity for the C-cap. However, Gly was clearly most often found at the
C-cap. Based on the results of this study, Richardson and Richardson speculated if the
substitution of strongly preferred amino acids in correct locations would stabilize helices
or whole proteins. However, for the purposes of this study on MS2 as a platform for
peptide display, other structural considerations would have to be evaluated as well.
If secondary structure propensities represented a new opportunity to manipulate
peptides in a phage display context, then E-structures must also be considered. As a
review of current literature reflects, E-sheet propensities have proven to be more difficult
to determine as opposed to those from D-helices [21]. The fact that E-sheets do not
appear to fold in isolation and conflicting experimental data from several model systems
appears to be the reason for this problem [21, 22]. Additionally, the fact that E-sheets can
exist as parallel or anti-parallel strands further complicates the elucidation of E-sheet
propensities. Simply put, amino acid residues in a parallel conformation could express
different folding effects when positioned in an anti-parallel orientation. Thus, even the
orientations of amino acid residues in a particular secondary structure are a consideration
when trying to revert folding defects.
As in the case of helices, several models have emerged that support the initiation
and termination of E-sheets. One model suggests that side chain interactions can
sterically prevent the establishment of hydrogen bonds between adjacent amino acid
residues and solvent [23]. Another, more recent model, suggests that E-sheet propensities
are guided by the tendency to minimize the surface area of E-strand backbones [24].
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However, neither model fully clarifies the interactions of amino acid residues in E-sheets.
One model, albeit equally incomplete, appears to better clarify this relationship between
amino acids and the formation of E-sheet secondary structure. In this model, sheet
propensity is characterized as simply the avoidance of steric clashes between sheet
backbone and residue side chains [21]. However, because this model does not delineate
position specific E-sheet propensities, extracting useful de novo protein design cues
would be limited.
A recent study extended the work of Street, Mayo, and others to actually identify
capping propensities for E-sheets. In this study, Asp, Asn, Pro, and Ser were identified as
E-sheet terminators, while Lys and Arg emerged as E-sheet initiators in both parallel and
anti-parallel strands [22]. This effort re-emphasized the importance side-chain sheet
backbone interactions and could, if successful provide some insight into a mechanism for
stabilizing N-terminal insertions in MS2. One other key finding of this effort related to
the under-representation of Asp and Asn in E-sheet interiors. FarzadFard et al. theorized
that the interactions of these two amino acids in the interiors of E-sheet could limit
backbone-backbone interactions typically seen between partner strands. Thus, the
limiting interactions of Asp and Asn could prove to be detrimental to E-sheet formation.
Taken in context, this additional outcome could prove to be useful for de novo protein
design considerations.
After review of these early experiments on helices and sheets, a key research
question emerged - could amino acids be strategically employed to influence peptide
insertions? In order to do so effectively, amino acids cannot confer any significant
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constraints on the random peptide targeted for insertion. In fact, if peptides do become
constrained, it has been suggested that a library constructed from these sequences would
represent less conformational complexity than peptides in an unconstrained library [1].
Additionally, as it has been noted in other efforts, random peptides will not generally fold
into defined secondary structures [1]. Therefore, successful strategic placement of amino
acids around a peptide must have subtle impact, and most importantly, preserve
maximum conformational complexity. In this same review by Smith and Petrenko, it was
also noted that peptides could become constrained within the framework of a protein
scaffold. More precisely, E-structures or D-helices have the ability to impart structural
constraints on inserted peptides- especially in the context of phage display. However,
this particular literature review was trying to infer that the constraints imparted by Esheets, D-helices, or other secondary structure motifs would be beneficial to peptides
given that they mostly lack structures of their own [1]. With this in mind, it should also
be noted that peptides do not natively exist in one rigid structural conformation. Instead,
HYHQLQWKHFDVHZKHUHDSHSWLGHLVµKHOLFDO´SHSWLGHVUHDGLO\PRYHEHWZHHQQRQ-helical,
helical, and partially helical arrangements [25]. Therefore, it is conceivable that
employing selected amino acids to influence the presentation of peptides within the
context of phage display could have detrimental, unintended consequences.
Whether the context is a D-helix or a E-structure, amino acids have been shown to
influence the propagation of secondary structures [15, 16, 22, 25, 26]. Most research
efforts have focused specifically on understanding the role of amino acids at the
boundaries of E-sheets and D-helices. However, amino acid propensities have also been
established for positions that span across a given secondary structure [18, 21, 26, 27]. In
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the case of D-helices, propensities have even been shown for amino acids 15 residues in
from the n-terminus [27]. The implication here was that amino acid residues throughout
the length of a defined secondary structure all work in concert to govern the overall
nature of the protein in which they reside. Therefore, in the case where we seek to revert
n-terminal folding defects in bacteriophage MS2, flanking residues may not exert as
much structural influence as once thought. Instead, these flanking amino acids may
simply interact favorably with the backbone of the recombinant peptide- thereby allowing
the inherent structural nature of the inserted peptide to be conveyed.
Stereochemical Initiation/T ermination of Secondary Structures
The AB-loop of bacteriophage MS2 has recently shown initial promise in being
able to present viral epitopes and stimulate B-cells [12]. During preliminary experiments
for this effort, it was quickly recognized that the use of the single-chain dimer would be
required to allow for effective peptide presentation in the AB-loop. As illustrated in Fig.
5, once the coat sequence of MS2 was effectively duplicated, two AB-loop sites become
available for potential peptide presentation. For point of clarity, the upstream (blue) ABORRSUHJLRQKDVEHHQODEHOHGDVWKH¶LQVHUWLRQVLWH-with the downstream AB-loop region
UHG ODEHOHGDVWKH¶LQVHUWLRQVLWH
As preliminary efforts began to progress on the viability of the MS2 platform for
YDFFLQHDSSOLFDWLRQVLWZDVREVHUYHGWKDWWKH¶$%-loop insertion site, even in the
context of the single-chain dimer, remained mostly refractory to random peptide
insertions (data not shown). This was surprising given the observation that peptide
LQVHUWLRQVLQWKH¶$%-loop are well tolerated in the single-chain dimer [12]. We
DVVXPHGWKDW¶LQVHUWLRQVZHUHFOHDUO\EHQHILWLQJIURPEHLQJLQWKHFRQWH[WRIDVLQJOH26

  
FKDLQGLPHU&RQYHUVHO\ZHDOVRVSHFXODWHGWKDW¶LQVHUWLRQVFRXOGSRWHQWLDOO\
destabilize the overall single-chain dimer. If, as the single-chain dimer begins to form, the
upstream coat sequence remains improperly folded, then even a viable downstream wildtype coat sequence cannot provide sufficient stability to overcome this defect. With this
in mind, initial attention turned to opportunities tRVWDELOL]H¶UDQGRPLQVHUWLRQV
A group of researchers working with hepadnavirus employed a combinatorial
approach to maximize peptide incorporation. In this system, the research group observed
WKDWWKH³RSWLPDOFRPELQDWLRQ´RILQVHUWLRQVLWHFRXSOHG with flanking acidic amino acids
could allow for maximum incorporation of foreign sequences [9]. Thus, it was postulated
WKDWLQVHUWLRQVLQWRWKH¶$%-loop of MS2 could benefit from the efforts of Billaud et al.
Indeed, incorporating charged amino acids to stabilize random insertions seemed
innovative. However, Billaud et al., correctly highlight other factors including
hydrophobicity, high E-strand index, insertion length, etc., for consideration in reverting
folding defects. The ideas presented in this study represented a starting point for
reverting AB-loop failures. However, it was clear that other approaches would need to be
considered.
The concept that amino acids confer intrinsic structural information for native
proteins as they fold into their final conformations is not new. In a hallmark paper, a
mechanism was proposed that suggested beta strand and helix formation originated
centrally within a polypeptide and spread bi-GLUHFWLRQDOO\XQWLO³WHUPLQDWLQJ´UHVLGXHV
were encountered [18, 19]. Given that two beta strands bound the AB-loop of MS2,
attention was turned to opportunities to manipulate beta structures. A quick review of
current literature revealed that E-sheet propensities have proven to be much more difficult
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to resolve [21]. However, several models have been proposed to describe the initiation
and termination of E-sheets. One model proposes that side chain interactions work to
prevent the hydrogen bond interaction that occurs between adjacent amino acid residues
and solvent [23]. Another model posits that E-sheet propensities are guided by an
inherent need to minimize the surface area of E-strand backbones [24]. However, one
model simply describes sheet propensity as the minimization of unfavorable interactions
between sheet backbone and residue side chains [21]. In 2008, a research team extended
this simple approach and developed a model for the capping propensities of E-sheets.
Asp, Asn, Pro, and Ser emerged as E-sheet terminators, while Lys and Arg were
identified as E-sheet initiators [22]. With this data now in hard, we speculated if the
propagation of secondary structures could be terminated by the strategic placement of
amino acids? Additionally, could the effects of randomized sequences inserted into the
¶$%-loop be minimized with the same approach?
As emphasis has been made on employing amino acids to positively influence
random sequence incorporation into the AB-loop of MS2, other cellular activities may
also provide direct opportunities to revert folding defects. As we will explore further in
detail, we suggest the possible recruitment and interaction of molecular chaperones with
arginines as a novel folding mechanism for MS2 display. Briefly, the premise behind this
approach was that the incorporation flanking arginines around a recombinant peptide
region would recruit DnaK and encourage coat folding. In the case of the AB-loop, we
expect that arginines will ultimately allow for recombinant coat sequences to fold.
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E xploitation of C ellular Processes that E nhance Folding
As consideration has been given to utilizing amino acids to directly modulate
peptide insertions into MS2, other cellular processes may also offer equally innovative
opportunities to revert folding defects. Of particular significance is the potential use of
molecular chaperones. Scientists that employ filamentous phage in protein engineering
applications readily acknowledge limitations in the types of peptides incorporated into
this display system. With these limitations in mind, numerous attempts have been made
to identify other cellular mechanisms to improve peptide incorporation into filamentous
phage. Recently, a group employed the twin-arginine translocation (Tat) pathway to
transport and integrate a particular protein into filamentous phage [28]. Central to this
effort was the understanding that bacteria employ several pathways to generate and
deliver proteins to designated cellular locations. Of these pathways, the secretory (Sec)
pathway represents a general means by which proteins are exported to the periplasm [29].
In this pathway, proteins are exported to the periplasm in an unfolded state utilizing a
signal peptide sequence. This signal sequence, generally composed of hydrophobic
amino acids, allows for efficient targeting of Sec cellular machinery involved in peptide
export [29].
As in the case of proteins designated for the Sec pathway, many proteins must
interact with specific cellular machinery to achieve suitable final fold geometries.
Proteins can be targeted exclusively for folding in the cytoplasm as well as for the extracytoplasmic space. To achieve this specific level of protein targeting, signal sequences
are often encoded as part of the nascent peptide. Chaperones or other cellular machinery,
in turn, recognize these signal sequences and direct protein folding and export. In the
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case of the Tat pathway, proteins are delivered for translocation pre-folded. Thus, there
exists a tight coupling between signal sequence and compartment-specific chaperones to
ensure appropriate folding [29-33]. With this in mind, researchers speculated that some
refractory proteins could be incorporated into filamentous phage via the Tat pathway
given that proteins in this pathway would be pre-folded [28, 34].

In order to accomplish

Tat pathway activation, a cleavable N-terminal signal peptide derived from proteins
having Tat interaction was integrated into a reference protein and tracked [28, 33, 34].
The results of these experiments demonstrated that Tat targeting ensured proper peptide
incorporation and display in filamentous phage.
Bacteriophage MS2, as a new platform for phage display, does not require
periplasmic assembly to allow for virus-like particle formation. Instead, MS2 assembly
occurs entirely in the cytoplasm. Preliminary recombinant experiments at the n-terminus
of MS2 coat also uncovered refractory peptide sequences. Although MS2 coat, because
of its cytoplasmic assembly, initially appears to be unsuitable for Tat-mediated peptide
incorporation, Tat pathway activation could actually prove to be useful for peptide
integration and display. Central to the Tat pathway is the requirement that proteins be
delivered to this translocation system pre-folded. It is, therefore, not unreasonable to
assume that other cellular machinery, including molecular chaperones, are involved in
this process. A recent study looked at the role of molecular chaperones in the Tat
pathway and identified a potentially significant role for DNAK. In this study, it was
found that DNAK played an intimate role in protein folding prior to protein translocation
via the Tat pathway [33]. Specifically, DnaK maintained the stability of tat-mediated
proteins prior to translocation ± even under conditions where Tat-specific machinery
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were saturated [33]. This ability to promote efficient folding and to maintain proteins as
³H[SRUW-FRPSHWHQW³UHSUHVHQWHGDSURFHVVZLWKLPSOLFDWLRQVIRUUHVFXLQg misfolded
proteins.
In other studies, DnaK has been shown to have binding specificity for arginine
and lysine at its boundaries [35-37]. As suggested by its name, the twin arginine
translocation pathway is distinguished by its hallmark twin arginine motif in the signal
sequence that modulates it activation. Thus, by extension, it was proposed as part of this
effort that sequences flanked by arginines would allow for efficient incorporation of
refractory peptides into a MS2 VLP. Its was anticipated that by flanking a recombinant
region with arginines, that DnaK would be recruited along with other co-factors to aid in
nascent peptide folding and stabilization. With this mind, some mention must be made of
DnaK peptide binding in general. We proposed to flank a recombinant region attached to
MS2 coat protein with two arginines on each side because we believed that DnaK binding
to this protein would be enhanced by their inclusion. Similar findings have been
confirmed by several studies [35, 38]. Thus, we sought to demonstrate that the
incorporation of randomized insertions at the N-terminus of RNA bacteriophage MS2
coat protein could be greatly enhanced through the selective, engineered addition of
amino acids.
A pproaches to the Suppression of Defects imparted by N-T erminal Peptide Fusion.
The N-terminus of bacteriophage MS2 coat protein has been our primary focus in
developing a new location to display random peptide sequences. As experimental
activities commenced for this effort, N-terminal attachment of peptides appeared to
inhibit folding or generate assembly-incompetent clones. However, the strategic
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placement of amino acids and the potential recruitment of molecular chaperones emerged
as two new approaches to revert improperly folded recombinant proteins. As these two
key technical approaches were being developed, other opportunities were also identified.
One such opportunity related to efforts to display random insertions in filamentous
phage.

Mosaic VLPs
Filamentous phage display systems can be classified based on the coat gene being
exploited for presentation. For example type 88 vectors denote that a phage genome
encompasses two types of pVIII coat molecules [1, 39, 40]. In the context of phage
display, type 88 systems signify that one coat gene is recombinant and the other coat gene
is wild-type. The virion that emerges from this system is a mosaic in that both coat
molecules are present in the final particle. A variation on a type 88 phage display system
is the type 8+8 system. This system produces a mosaic phage particle from VIII genes
encoded on separate genomes.
In this case, the genome that encodes the wild-type coat sequence is called a
helper phage[1]. The recombinant coat sequence, on the other hand, represents a unique
type of plasmid called a phagemid [41, 42]. A key feature of this phagemid system is
that this type of plasmid encodes a replication origin amenable to E. coli hosts and
antibiotic resistance to aid in selection. Additionally, phagemids also encode the
filamentous phage origin of replication. This origin is dormant until cell is infected with
helper phage. Once both genomes are in the cell, both coat sequences are expressed in
progeny virus particles. It was this dual genome approach that prompted laboratory
efforts to design a system in which n-terminal recombinants would be co-expressed with
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wild-type MS2 coat proteins. The expectation was that mosaic capsids would be
produced and that this novel assembly pathway would allow poorly folded or assemblydeficient n-terminal MS2 coat recombinants to be rescued.

Genetic Selection for Stabilizing Bracket Sequences
As part of our first approach, we considered combinatorial approaches proposed
in the literature to influence the incorporation of peptides. However, many of these
approaches were specific to the phage systems from which they were derived.
Additionally, their applicability to the challenges encountered in this MS2 coat effort
may be limited. Masking the nature of peptide insertions emerged as a leading technical
option. Again, this approach was inspired by the combinatorial approach applied in the
generation of woodchuck hepadnavirus-like particles [9]. We extended the effort
described by Billaud et al., and eventually identified flanking amino acid combinations
capable of reverting insertion failures.
As a follow-up, a second, rather simplistic question emerged to offer a different
perspective on the use of flanking amino acid residues. Could nature offer a better
solution than simply employing propensity models or acidic sequences to stabilize
peptide insertions? If so, how could nature, or more appropriately, natural selection yield
a similar, or even better outcome? With this in mind, a new experimental approach was
established in which a recombinant sequence known to induce folding failures was
flanked by two randomized amino acid positions. The choice for randomizing two
flanking positions was based on experimental data suggesting that this was the minimum
configuration required to maintain insertion stability at the N-terminus. Taken in context,
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this additional outcome could prove to be useful for de novo protein design
considerations.
In the present study, we have identified and characterized amino acid sequences
that promote the effective incorporation and display of randomized sequences in
bacteriophage MS2 VLPs. We demonstrate that peptide design cues from nature can be
systematically employed to achieve peptide incorporation. We also suggest a
methodology to employ mosaic virus-like particles for presentation of refractory
sequences. Finally, we suggest a methodology to recruit cellular molecular machinery to
aid in the folding of recombinant peptide sequences.
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M A T E R I A LS A N D M E T H O DS
Plasmid Constructions

N-Terminal Insertions
Single-chain dimer versions of all N-terminal recombinant coat sequences were
produced by duplication of the recombinant and wild-type coat sequences. The upstream
half that included the recombinant region was produced via PCR amplification. In this
FDVH¶-primers annealing to pCT119dl5N upstream of the coat sequence, and a
downstream primer creating a BglI UHVWULFWLRQVLWHDWWKH¶HQGRIWKHFRDWFRGLQJ
sequence were employed. The generated PCR products were subsequently digested with

HindIII and BglI to produce a fragment that contained the recombinant coat sequence
with a new BglI site. The downstream half was synthesized using a primer that created a

BglI VLWHDWWKH¶-end of the coat codinJVHTXHQFHDQGD¶-primer that annealed to
plasmid sequences downstream of coat. This downstream fragment was then digested
with BglI and Bam HI -which is a downstream restriction site encoded in the plasmid.
The upstream and downstream coat fragments were then joined by ligation to a vector
fragment generated via HindIII-Bam HI cleavage of pCT119dl5N, thereby creating the
required single-chain dimer construction. This process was repeated for all 12 primer
constructions to generate recombinant single-chain dimers. This arrangement is identical
to p2CT-dl13, but encoding two amino acid substitutions to create the required BglI site
[43].
The plasmid pACTdl5n, a pACYC-derived plasmid, incorporates the wild-type
MS2 coat sequence and has expression directed from the T7 promoter. pACET is a
control plasmid that does not generate coat protein. pACTdl5N and pACET were
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subsequently utilized to characterize the generation of mosaic MS2 coat capsids. pFCT
(which has previously been described) was employed to generate Flag fusions under the
control of the lac promoter [11]. pAFCT, which was constructed in a fashion similar to
pFCT, expresses Flag fusions under the control of the t7 promoter. To generate the
randomized bracket configuration, the PCR primer 5-GGCCATGGCT(NNY)2 ±
(LNLVFILLSG)-(NNY)2-GGCGGCGCTTCTAACTTTACTCAGTTC was employed.
NNY (where N is A, C, G, or T and Y is T or C) was utilized to generate the randomized
flanking sequences.
Briefly, the randomized N-terminal insertion was produced by PCR amplification
XVLQJDERYHPHQWLRQHG¶-primer that annealed at the NcoI VLWHDQGD¶-primer
downstream of a plasmid Bam HI restriction site. This PCR product was then digested
with NcoI and Bam HI, gel-purified and ligated to a similarly digested vector fragment
from pCT119dl5N. This PCR fragment was carefully recovered in ligated into a new
vector, pP7K. To generate this new randomizing bracket configuration, we first digested
plasmid pP7K with SapI and Bam HI. Then, in a three-part ligation, we digested the
recovered PCR fragments (derived from pCT119dl5N) with HindIII and Ba m HIII. As
we still required a SapI-HindIII fragment to complete the ligation, we digested
pCT119dl5N with SapI and HindIII to generate the final required fragment. The two
insert fragments were ligated with the pP7K vector and transformed into strain CSH41Fcontaining plasmid pRZ5 and plated on LB medium containing X-Gal [14].

A B-Loop Insertions
Single-chain dimer versions of all AB-loop recombinant coat sequences were
produced by duplication of the recombinant and wild-type coat sequences. The upstream
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half that included the recombinant region was produced via PCR amplification. In this
FDVH¶-primers annealing to plasmid sequences upstream of the coat sequence in
pMCTK2, and a downstream primer creating a BglI UHVWULFWLRQVLWHDWWKH¶HQGRIWKH
coat coding sequence were employed. The generated PCR products were subsequently
digested with HindIII and BglI to produce a fragment that contained the recombinant coat
sequence with a new BglI site. The downstream half was synthesized using a primer that
created a BglI VLWHDWWKH¶-end of the wild-W\SHFRDWFRGLQJVHTXHQFHDQGD¶-primer
that annealed to plasmid sequences downstream of coat. This downstream fragment was
then digested with BglI and Bam HI -which is a downstream restriction site encoded in the
plasmid. The upstream and downstream coat fragments were then joined by ligation to a
vector fragment generated via HindIII-Bam HI cleavage of pMCT [12], thereby creating
the required single-chain dimer construction. This arrangement is identical to p2CT-dl13,
but encodes two amino acid substitutions to create the required BglI site [43]. The new
construct is called p2MCTK5. It provides a single-chain dimer with a unique KpnI
restriction site in the AB-loop of the upstream half.
L ibraries of Random Sequence Peptides

N-Terminal Insertions
To insert random DNA sequences into the N-terminus, the primers described
below were used to amplify a coat fragment from pCT119dl5N in eight different
UHDFWLRQV7KH¶-primers that attach at an NcoI site were 5-ATGGCTAGCAGC(NNY)10AGCAGCGGCGGC-3, 5- ATGGCTACCACC-(NNY)10ACCACCGGCGGC-3,
5- ATGGCTGCGGCG-(NNY)10GCGGCGGGCGGC-3, 5- ATGGCTGGCGGC(NNY)10GGCGGCGGCGGC-3, 5- ATGGCTGACGAC-(NNY)10GACGACGGCGGC-3,
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5- ATGGCTGAGGAG-(NNY)10GAGGAGGGCGGC-3, 5- ATGGCT(NNY)10GAGGAGGAGGAGGGCGGC-3, and 5- ATGGCTAGGAGG(NNY)10AGGAGGGGCGGC-3. NNY (where N is A, C, G, or T and Y is T or C) is
utilized to generate the random intervening sequences. For modifications to serine
brackets, the following primers were used: 5- ATGGCTAGCAGC(NNY)10AGCAGCGGCGGC-3, 5- ATGGCTAGCAGC(NNY)10GGCGGC-3, 5ATGGCT-(NNY)10AGCAGCGGCGGC-3, and 5- ATGGCT(NNY)10AGCGGCGGC-3.
(DFKUHDFWLRQGHVFULEHGDERYHDOVRHPSOR\HGDVLQJOH¶-primer that annealed
downstream of a Bam HI site in the plasmid vector. The generated PCR products were
subsequently digested with NcoI and Bam HI, gel-purified and ligated to similarly
digested vector fragments from pCT119dl5N.

A B-Loop Insertions
To insert random DNA sequences into the AB-loop, the primers described below
were used to amplify a coat fragment from pMCT into six different recombinant
UHDFWLRQV(DFKUHDFWLRQXWLOL]HGDVLQJOH¶-primer that annealed upstream of a HindIII
VLWHLQWKHSODVPLGYHFWRU6L[GLIIHUHQW¶-primers (5CCGGTACCGCTGCT(RNN)10AGTTCC-GCCATT-3, 5- CCGGTACCATCATC(RNN)10AGTTCCGCCATT-3, 5-CCGGTACC-GCC(RNN)10AGTTCCGCCATT-3, 5CCGGTACCCGG(RNN)10AGTTCCGCCATT-3, 5- CCGGTACCGCGGCG(RNN)10GCGGCGAGTTCCGCCATT-3, and 5- CCGGTACCGCGGCGGCGGCG(RNN)10GCGGCGGCGGCGAGTTCCGCCATT-3) attach at a KpnI site. NNY (where
N is A, C, G, or T and Y is T or C) is utilized to generate the random intervening
sequences. The resulting PCR products were digested with KpnI and HindIII, gel-
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purified and ligated to similarly digested fragments of pMCTK2 or P2MCTK5. The
resulting plasmids were then introduced by transformation into strain CSH41Fcontaining plasmid pRZ5, and plated on LB medium containing X-Gal [14].
Protein E xpression, Purification, and Functional Assays
To test the recombinant proteins for translational repressor function, each plasmid
was introduced into E. coli strain CSH41F± containing the translational repression
reporter plasmid pRZ5 and plated on LB medium containing 5- bromo-4-chloro-3indolyl-ȕ-d-galactoside (X-Gal) [14]. Control ligations containing only vector DNA
produced at least 1000-fold fewer colonies than ones with an inserted sequence. After
overnight incubation, blue and white colony counts were assessed. Again, properly
folded recombinant proteins repression translation of E-galactosidase and yield white
colonies. For each plasmid construction, 24 white colonies and 12 blue colonies were
picked to two different 1 mL cultures in LB medium and grown overnight with shaking at
37 °C. One set of cultures was employed for plasmid isolation and DNA sequence
analysis.
The second set was then lysed by sonication and subjected to agarose gel
electrophoresis. Note that after sequence analysis, a few white clones were dropped from
the analysis. A few clones either lacked a peptide insertion or contained mutations at
secondary sites that might complicate interpretation of the results. Assessment of a
recombinant protein's ability to assemble into a VLP was performed by electrophoresis of
sonicated cell lysates (from 1 mL overnight cultures) in gels of 1% agarose in 50 mM
potassium phosphate, pH 7.5 [44]. Gels were then stained with ethidium bromide to
intercalate with host RNAs to indicate the presence of VLPs. Verification of VLPs was
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then confirmed by transferring gel contents to nitrocellulose. This was then probed with
rabbit anti-MS2 serum and finally resolved with an alkaline phosphatase-labeled second
antibody.
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R ESU L TS: N-T E R M I N A L F USI O NS
Insertion of Randomized Peptides in the N-T erminus of MS2 Coat Protein
As illustrated in Figure 6, the N-terminus of RNA bacteriophage MS2 is located
at the surface of the viral capsid. It was due to the potential to exploit this surface
accessibility in immunological applications that previous research focused on this area
for peptide insertion [11]. In a foundational study, the Flag peptide, which has been
utilized to immunologically tag and track proteins, was successfully incorporated at the
N-terminus of MS2 [11]. To facilitate N-terminal incorporation of the Flag peptide, a
plasmid, pCT119dl5N, was constructed from pCT119 as previously described [11, 14]. It
possesses an Nco I site at the translational start codon, and thus facilitates fusion of
peptides to the N-terminus. As described in the Introduction, a previous study inserted the
Flag peptide and this site. The protein seemed to fold properly, but was unable to
assemble into VLPs. Utilization of the single-chain dimer largely corrected the assembly
defect.
In the present study, pCT119dl5N was again utilized to generate fusion proteins at
the N-terminus of MS2. Primers containing either a random ten amino acid sequence or a
random ten amino acid sequence flanked by other amino acids were synthesized and
subsequently used to generate recombinant proteins (Figure 7a,b). The resulting
plasmids, pCT119dl5n-(NNY)10 ,pCT119dl5n-XX(NNY)10XX, and pCT119dl5n(NNY)10XXXX were employed to express all recombinant proteins for this study. X, in
all cases, was represented by a specific amino acid suggested in the literature as
providing potential benefit in this recombinant effort and are referenced accordingly (Fig.
3b). The NNY triplet (N= any nucleotide, Y= T or C) was utilized to generate the
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intervening random peptide region because it produces 15 out of the 20 standard amino
acids. Although Met, Gln, Trp, Lys, or Glu are not produced in NNY libraries, this
approach avoided the incorporation of stop codons, which obviously would have resulted
in failure to produce the peptide-coat fusion.
Tests of translational repression demonstrated that the vast majority of (NNY)10
random insertions at the N-terminus were essentially repressor-defective, presumably
indicating interference with proper coat protein folding. However, the selective
incorporation of amino acids in the form of XX(NNY)10 XX, and (NNY)10XXXX
generally produced recombinants that were effective in repressing E-galactosidase
production. These results were expressed as a percentage of clones repressing translation
(Table II). The beneficial effect of the incorporation of either glutamate or aspartate
brackets (Table II) is consistent with the results of Ballaud et al. obtained earlier with
hepadnavirus VLPs (see ref. [9] and the Introduction). The presence of glutamate or
aspartate brackets increased the tolerance of a 10-mer insertion from a baseline of 2%
functional repressors to a high of almost 80%.
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F igure 6. A lternative view of MS2
(a) The structure of the Bacteriophage MS2 coat protein dimer with polypeptide chains
highlighted in blue and red. The N-terminus for each polypeptide is designated by the
first four amino acids in its chain. (b) Structure of the MS2 coat protein dimer. The
proximity of the N-terminus of one coat monomer to the C-terminus of the other coat
monomer allows the single-chain dimer to be constructed.

F igure 7. Summary of N-terminal efforts
(a) Arrangements of the coat protein reading frames on the plasmids used in this
experiment. All express coat protein from the lac promoter. Plasmid p2CT119DL5N
expresses a single-chain dimer version of the protein. Black boxes represent the peptide
insertions made in each plasmid configuration. (b) Oligonucleotides utilized to make
insertions in each plasmid configuration.
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T able I I. N-terminal monomer functional repressors.
The percentages of 10-mer N-terminal insertions that result in functional translational
repressors. Results are shown for monomer configuration (white colonies on X-Gal
plates).
Monomer Platform

Percent White Colonies

pUC119
Control
0
pCT119dl5n (pC5n)
Control
100
pC5n- (NNY)10
Random Insertion
2
pC5n- EE(NNY)10EE
+Glutamate Brackets
65
pC5n- DD(NNY)10DD
+Aspartate Brackets
79
pC5n- (NNY)10EEEE
+Glutamate Cloud
65
pC5n- SS(NNY)10SS
+Serine Brackets
70
pC5n- TT(NNY)10TT
+Threonine Brackets
18
pC5n- AA(NNY)10AA
+Alanine Brackets
2
pC5n- GG(NNY)10GG
+Glycine Brackets
5
pC5n- RR(NNY)10RR
+Arginine Brackets
77
Controls are pUC119, which produces no coat protein. Plasmid
pCT119dl5n (pC5n) produces wild-type coat protein.
T able I I I. N-terminal dimer functional repressors.
The percentages of 10-mer N-terminal insertions that result in functional translational
repressors. Results are shown for single-chain dimer configuration (white colonies on XGal plates).
Single-C hain Dimer
Platform

Percent VLP Formation

pUC119
Control
0
p2M
Control
100
p2M- (NNY)10
Random Insertion
8
p2M - EE(NNY)10EE
+Glutamate Brackets
88
p2M - DD(NNY)10DD
+Aspartate Brackets
79
p2M - (NNY)10EEEE
+Glutamate Cloud
70
p2M - SS(NNY)10SS
+Serine Brackets
88
p2M - TT(NNY)10TT
+Threonine Brackets
42
p2M - AA(NNY)10AA
+Alanine Brackets
7
p2M - GG(NNY)10GG
+Glycine Brackets
39
p2M - RR(NNY)10RR
+Arginine Brackets
94
Controls are pUC119, which produces no coat protein. Plasmid
p2Mproduces a wild-type coat dimer protein.
44

  
The other amino acid choices listed in Table IV reflected the culmination of an extensive
literature review on the incorporation of amino acids in nascent peptides [15, 16, 18, 19,
22, 25]. Serine and arginine emerged as two other amino acid partners that allowed
randomly generated 10-mer sequences to repress translation. In the cases of serine and
arginine, baseline repression increased from 2% in the random 10-mer to 70% and 77%
respectively.
Incorporating Peptide Fusions into the Single-C hain Dimer
Although several bracket configurations allowed E-galatosidase repression, none
of the recombinants constructed as fusions to wild-type coat protein were competent for
VLP formation (Table II). We suspect that this failure of apparently properly folded coat
proteins to assemble into VLPs is due to crowding at local 3-fold symmetry axes where
N-termini of three adjacent coat proteins come into close proximity, a problem which is
reduced when fusions are introduced into the single-chain dimer. As illustrated by the
results, a striking improvement in repression was observed for N-terminal recombinants
when the single-chain dimer was incorporated in conjunction with brackets (Table III).
With the noted exceptions of the baseline random 10-mer insertion and alanine brackets,
percent white colony counts improved across all recombinant variations.
MS2 V L P Formation
A properly assembled VLP stains with ethidium bromide and reacts with coatspecific antiserum. To monitor VLP formation, sonicated cell lysates from individual
clones were subjected to agarose gel electrophoresis. VLPs were visualized by staining
with ethidium bromide ±which intercalates with and stains the RNA they encapsidate.
Gels were also blotted to nitrocellulose and probed with anti-MS2 serum and alkaline
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phosphatase conhugated anti-rabbit IgG [11, 45]. Note that VLP mobility varies with
changes in surface charge associated with the insertion of peptides and flanking brackets
(Figure 8).

F igure 8. Serine bracketed V L P formation
Electrophoresis on agarose gel of VLPs identified in lysates of cells producing
recombinant coat proteins. The first two lanes of each gel are controls: pCT119 produces
wild-type coat, while pUC produces no coat protein. An Ethidium bromide-stained gel
(left panel) and western blot probed with MS2 anti-serum (right panel) for serinebracketed recombinants are shown.
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T able I V . N-terminal monomer V L P formation
The percentages of 10-mer N-terminal insertions that suggest positive VLP formation in
monomer (positive ethidium bromide staining in capside gel, western blot for MS2 coat).
Monomer Platform

Percent VLP Formation

pUC119
Control
0
pCT119dl5n (pC5n)
Control
100
pC5n- (NNY)10
Random Insertion
0
pC5n- EE(NNY)10EE
+Glutamate Brackets
0
pC5n- DD(NNY)10DD
+Aspartate Brackets
0
pC5n- (NNY)10EEEE
+Glutamate Cloud
0
pC5n- SS(NNY)10SS
+Serine Brackets
4
pC5n- TT(NNY)10TT
+Threonine Brackets
0
pC5n- AA(NNY)10AA
+Alanine Brackets
0
pC5n- GG(NNY)10GG
+Glycine Brackets
4
pC5n- RR(NNY)10RR
+Arginine Brackets
0
Controls are pUC119, which produces no coat protein. Plasmid
pCT119dl5n (pC5n) produces wild-type coat protein.
T able V . N-terminal dimer V L P formation.
The percentages of 10-mer N-terminal insertions that suggest positive VLP formation in
dimer (positive ethidium bromide staining in capside gel, western blot for MS2 coat).
Single-C hain Dimer
Platform

Percent VLP Formation

pUC119
Control
0
p2M
Control
100
p2M- (NNY)10
Random Insertion
0
p2M - EE(NNY)10EE
+Glutamate Brackets
4
p2M - DD(NNY)10DD
+Aspartate Brackets
4
p2M - (NNY)10EEEE
+Glutamate Cloud
4
p2M - SS(NNY)10SS
+Serine Brackets
100*
p2M - TT(NNY)10TT
+Threonine Brackets
4
p2M - AA(NNY)10AA
+Alanine Brackets
0
p2M - GG(NNY)10GG
+Glycine Brackets
4
p2M - RR(NNY)10RR
+Arginine Brackets
0
Controls are pUC119, which produces no coat protein. Plasmid
p2Mproduces a wild-type coat dimer protein. *Greatest impact on VLP
formation
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C haracterizing the E ffects of A mino A cid B rackets
Given that di-serine brackets produced the highest overall white colony count, and
yielded the highest number of VLPs, we randomly selected 5 blue recombinants for
sequence analysis to determine whether their failure to repress translation was indeed due
to a protein folding failure or to some defect in their construction that might fail to yield
the desired fusion protein. In a previous effort, we noticed that some reportedly repressordefective clones in a phage library were the results of oligonucleotide synthesis errors
that yielded frameshift mutations or of aberrant ligation events [12]. In fact, four of the
five blue di-serine bracket clones proved to contain frameshift mutations (results not
shown). Therefore, again, a noteworthy percentage of repressor-defective clones in this
library were not the consequence insertion failures, but rather due to other defects.
Determining the Importance of Individual Serines in the B rackets.
To determine the importance of individual serines in the serine bracket
configuration, serines were selectively removed and the functional consequences were
determined (Figure 9). As suggested by the data, serine change 42
(ATGGCT(NNY)10AGCGGCGGC in dimer) appeared to have the greatest impact on the
folding behavior of N-terminal recombinant proteins (see Table VI). Serine bracketed
recombinants in the single-chain dimer started with a baseline of 88% repression
effectiveness. The change imparted by the 42-configuration moved repression downward
to a low of only 1%. Thus, the 42-configuration yielded a dramatic downward impact on
recombinant folding behavior. With regard to assembly, serine change 12
(ATGGCTAGCAGC(NNY)10GGCGGC in dimer) had a dramatic impact on VLP
formation for N-terminal extensions (Table VI). In this case, serine bracketed
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recombinants started with a baseline of 100 % VLP formation. However, once serines
were removed to reflect the 12-configuration, VLP formation fell from 100% to low of
4%.

F igure 9. Codons for serine modification study
Codons of the oligonucleotides utilized to make insertions in each plasmid configuration.
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denotes the changes made to the original serine bracketed insertion.
T able V I. V L P formation for serine modifications.
The percentage of serine-bracketed N-terminal insertions suggesting proper folding
(white clones) and proper assembly (VLP formation). SRX1 defines the monomer
baseline configuration, while SRX2 identifies the single-chain dimer baseline. SR42 has
the greatest impact on folding behavior, while SR12 indicates a dramatic impact on VLP
formation.
Serine Changes
Percent White clones
SerX1 Monomer
70
SR11
46
SR31
61
SR41
49
SerX2 Dimer
88
SR12
92
SR32
99
SR42
1**
**denotes greatest net change in baseline protein behavior
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Percent VLP Formation
4
0
0
4
100
4**
96
83

  

R ESU L TS: P E P T I D E I NSE R T I O NS I N T H E UPST R E A M A B-L O O P
O F T H E SI N G L E-C H A I N D I M E R
Insertion of E ngineered Randomized Peptides in the A B-loop of MS2 Coat Protein
As illustrated (Figure 10), the AB-loop of RNA bacteriophage MS2 is located at
the surface of the viral capsid, an ideal site for peptide display. In fact, recent efforts to
exploit this surface accessibility and incorporate peptides for immunological applications
have shown considerable promise [12]. In this 2008 study by Peabody et al., it was
demonstrated that a high frequency of peptide insertion tolerance (greater than 95%) was
obtained when the insertions were confined to the AB-loop of the downstream half of a
single-chain dimer. Insertions in the AB-loop of wild-type coat protein, or in both halves
of the single-chain dimer nearly always resulted in a sever folding defect. To facilitate
insertions a Kpn I site was produced by silent mutations in codons 14 and 15 [11, 14]. In
this case insertion introduced a duplication of codons 14 and 15 within the AB-loop ±
resulting in 12, not 10 amino acid inserted.
PCR primers containing either a random ten amino acid sequence or a random ten
amino acid sequence flanked by the selective incorporation of other amino acids were
synthesized and subsequently used to generate recombinant proteins for the present effort
(Figure 11a,b). Literature reviews had suggested the use of structure-terminating amino
DFLGVLH³VWHUHRFKHPLFDOSXQFWXDWLRQPDUNV´RU³JDWHNHHSHUV´WRVWRSWKHSURSDJDWLRQ
of secondary structures [22, 25, 46, 47]. Our premise for this effort was that the
introduction of random sequences potentially extended or introduced nascent secondary
structures. Therefore, it seemed logical to employ amino acids shown to cap or provide
WHUPLQDWLRQRIVWUXFWXUHDVWKHVHLQVHUWLRQVZHUHPDGHLQWRWKH¶ORRSRI067KH
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resulting plasmids, pMCTK2-(NNY)10 ,pMCTK2-(NNY)10XX, pMCTK2XX(NNY)10XX and pMCTK2-XXXX(NNY)10XXXX were employed to express all
recombinant proteins for this study. X, in all cases, was represented by a specific amino
acid suggested in the literature as providing potential benefit in this recombinant effort
and are referenced accordingly (Figure 11b). The NNY triplet (N= any nucleotide, Y= T
or C) was utilized to generate the intervening random peptide region because it produces
15 out of the 20 standard amino acids. Although Met, Gln, Trp, Lys, or Glu are not
produced in NNY libraries, this approach avoided the incorporation of stop codons and
consequently limited the inclusion of truncated sequences in downstream analyses.
The -galactosidase repression assay was again utilized to assess the folding
behavior of recombinants coat sequences. Functional tests demonstrated that (NNY)10
random insertions in the AB-loop of the wild-type protein were essentially all repressor
defective. Additionally, the selective incorporation of amino acids yielded no
recombinants that were effective in repressing -galactosidase production.

F igure 10. A B-loop of MS2
(a) The structure of the Bacteriophage MS2 coat protein dimer, with polypeptide chains
highlighted in blue and red. The AB-loop for each polypeptide is designated by the
enlarged, filled amino acids in its chain. (b) Structure of the MS2 coat protein dimer. The
closeness of the N-terminus of one coat monomer to the C-terminus of the other coat
monomer allows for the single-chain dimer to be constructed.
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F igure 11. Recombinant insertions in A B-loop
(a) Arrangements of the coat protein reading frames on the plasmids used in this
experiment. All express coat protein from the lac promoter. Plasmid pMCTK is similar
to the previously described pCT119[11, 14], except for KpnI site that also incorporates
the coat protein initiation codon (delineated by arrow). Plasmid p2MCTK5 expresses a
single-chain dimer version of the protein. Black boxes represent the peptide insertions
made in each plasmid configuration. (b) Oligonucleotides utilized to make insertions in
each plasmid configuration. As AB-$''("
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generate recombinant inserts, the orientation of the nucleotides and random insert reflect
an anti-sense orientation.
T able V I I. A B-loop monomer functional repressors.
The percentages of 10-% 
*
 9-loop insertions that result in functional translational
repressors (white colonies on X-Gal plates).
Monomer Platform

Percent W hite Colonies

pUC119
Control
0
pMCTK2
Control
100
pMCTK2-(NNY)10
Random Insertion
ND
pMCTK2-(NNY)10SS
+Serine
0
pMCTK2-(NNY)10DD
+Aspartate
0
pMCTK2-(NNY)10GG
+Glycine
2
pMCTK2-RR(NNY)10RR
+2Arginine
1
pMCTK2+4Arginine
3
RRRR(NNY)10RRRR
Controls are pUC119, which produces no coat protein and, as a result,
yields no repression. Plasmid pMCTK2 produces wild-type coat protein
and explicitly represses translation. ND= not detected
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Folding Defects are Suppressed by Incorporation Into the Single-C hain Dimer
It was previously demonstrated that genetic fusion of two coat protein chains can
efficinetly suppress folding/stability defects imparted by peptides inserted into the ABloop when they are confined to the C-terminal half of the single-chain dimer [12]. Here
we sought to determine whether the single-chain dimer similarly accommodates
insertions in the N-terminal half of the single-chain dimer. We also wanted to determine
ZKHWKHUEUDFNHWLQJDPLQRDFLGVDIIHFWWKHSURWHLQ¶VWROHUDQFHRILQVHUWLRQV7RIDFLOLWDWH
peptide insertion, we constructed plasmid p2MCTK5. This plasmid is also similar to a
previously described plasmid, p2CTdl13, and relates to pMCTK2 in its construction [11,
14]. However, in this case, a KpnI LQVHUWLRQVLWHLVJHQHUDWHGLQWKH¶RUXSVWUHDPORRS
only. Implementation of the single-chain dimer increased repression analysis
significantly (Table VII). Engineered serine and quad arginine recombinant generated the
highest number of repression-competent clones.
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T able V I I I. A B-loop dimer functional repressors.
The percentages of 10-PHU¶$%-loop insertions that result in functional translational
repressors (white colonies on X-Gal plates).
Single-C hain Dimer
Percent W hite
Platform
Colonies
pUC119
Control
0
p2MCTK5
Control
100
p2MCTK5-(NNY)10
Random Insertion
41
p2MCTK5-(NNY)10SS
+Serine
80
p2MCTK5-(NNY)10DD +Aspartate
74
p2MCTK5-(NNY)10GG +Glycine
51
p2MCTK5+2Arginine
71
RR(NNY)10RR
p2MCTK5+4Arginine
86
RRRR(NNY)10RRRR
Controls are pUC119, which produces no coat protein and, as a result,
yields no repression. Plasmid p2MCTK5 produces a dimerized wild-type
coat protein and explicitly represses translation.
E ngineered Single-C hain Dimer Insertions G enerate Recombinant MS2 V L Ps

A key outcome of this experimental effort was the expectation that the
introduction of AB-loop insertions would not prevent VLP assembly. To monitor VLP
formation, individual white or blue clones were obtained and subjected to analysis. First,
sonicated cell lysates from individual clones were subjected to agarose gel
electrophoresis. Next, these lysates were visualized with ethidium bromide staining. This
step was critical in that ethidium bromide intercalates with the nucleic acid normally
encapsidated by properly assembled virus-like particles. Although not definitive,
ethidium bromide staining established early evidence of VLPs that incorporated
LQVHUWLRQVDWWKH¶XSVWUHDPORRS of MS2.
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Once ethidium staining was completed, we then assessed VLP formation by
Western blot. Western blot analysis involved staining a blot with anti-MS2 serum,
followed by a resolution step with the application of alkaline phosphatase-conjugated
anti-rabbit IgG. As expected, AB-loop insertions in the dimer configuration did yield
VLPs (Table VIII). The results were expressed as a percentage of white clones that
yielded VLPs over the total number of white clones. In the single-chain dimer, the serine
termination cap yielded the highest percentage of VLP formation (Table VIII). Other
engineered sequences failed to yield VLP formation higher than that of the baseline insert
only condition. With recombinant MS2 VLPs being made up different amino acids, their
electrophoretic mobilities can be employed to further ascertain the presence of unique
recombinant VLPs (Figure 12). The VLPs generated by serine terminal capped
recombinants demonstrated the anticipated variable pattern in mobility.
T able I X . A B-loop V L P formation
The percentages of 10-mer AB-loop insertions that suggest positive VLP formation in
dimer (positive ethidium bromide staining in capside gel, western blot for MS2 coat).
Dimer Platform

Percent V L P
Formation

pUC119
Control
0
p2MCTK5
Control
100
p2MCTK5-(NNY)10
Random Insertion
42
p2MCTK5-(NNY)10SS
+Serine
75
p2MCTK5-(NNY)10DD +Aspartate
54
p2MCTK5-(NNY)10GG +Glycine
4
p2MCTK5+2Arginine
30
RR(NNY)10RR
p2MCTK5+4Arginine
8
RRRR(NNY)10RRRR
Controls are pUC119, which produces no coat protein. Plasmid
pCT119dl5n (pC5n) produces wild-type coat protein.

55

F igure 12. T ermine serines in A B-loop produce V L Ps
Electrophoresis on agarose gel of VLPs identified in lysates of cells producing
recombinant coat proteins. The first two lanes of each gel are controls: p2MCTK5
produces wild-type coat, while pUC produces no coat protein. An ethidium bromidestained gel (left panel) and western blot probed with MS2 anti-serum (right panel) for
serine-bracketed recombinants are shown.

56

R ESU L TS: T A R G E T E D A PPR O A C H ES T O N-T E R M I N A L
P E P T I D E D ISP L A Y
Co-E xpression of Flag-Coat Fusions with W ild-T ype Coat Produce Mosaic V L Ps
Co-expression of proteins to produce a mosaic virus-like particle represents a
common approach for filamentous phage peptide display. However, in the case of
bacteriophage MS2, such an effort has not been attempted. In anticipation of fold and
assembly problem with the introduction of a foreign sequence into the coat of MS2, we
proposed that co-expression could offer an alternative approach to address these
challenges. In a previous study, the Flag peptide was successfully incorporated into the
N-terminus of MS2 [11]. However, attempts to replicate the study yielded conflicting
results. In the present effort, two plasmids, pFCT and pAFCT, were employed to
generate Flag-coat fusions (Figure 13). Results of the repression assay in this effort again
demonstrated that the incorporation of the Flag peptide in both plasmid configurations
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-galactoside synthesis [11].
However, as VLP assembly was assessed, N-terminal constructions incorporating
the Flag peptide failed to produce viable capsid-like particles. As an alternative technical
approach, we then sought to generate mosaic capsids in which Flag fusion monomeric
proteins could potentially be displayed. The plasmid pCT119dl5n was again utilized to
produce fusion proteins at the N-terminus of MS2. Next, a second, inducible plasmid
(pACTdl5n) was constructed to support co-expression and eventually VLP assembly.
pACTdl5n, a pACYC-derived plasmid, incorporates the wild-type MS2 coat sequence
and has expression directed from the T7 promoter. To induce protein synthesis on this
plasmid, isopropyl-<-

-thiogalactopyranoside, IPTG was employed indirectly. IPTG,
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which is an analogue of lactose, has the ability to displace the lac repressor from the lac
operator. In our E. coli host, T7 polymerase is under the control of a lac promoter and
operator on the host chromosome.
Under normal conditions, this polymerase is effectively shut off via lac repressor
interaction. Once induced, however, host-derived T7 polymerase is synthesized and its
interaction with the T7 promoter on our inducible plasmid then directs coat synthesis. In
short, this inducible system allowed for very strong promoter to be employed without
sacrificing tight gene regulatory control. The resulting plasmid constructs, pCT119dl5nFlag (pFCT) and pACT119dl5n-Flag (pAFCT), were employed to express all
recombinant proteins for this study (Figure 13). As in the original study by Peabody,
neither plasmid incorporating the Flag peptide produced VLPs. To potentially remedy
these apparent assembly failures, a co-expression protocol was then employed to
potentially generate mosaic capsids.
In order to generate these mosaic capsids, two co-expression scenarios were
created. In the first scenario, wild-type MS2 coat was co-expressed with an inducible
Flag fusion coat sequence. For the second scenario, a Flag fusion coat construct was coexpressed with an inducible wild-type coat construction. Next, to verify that mosaic VLP
particles were actually being generated, a few control conditions were also established
(Table X). First, a wild-type coat sequence on a non-inducible plasmid was co-expressed
with an inducible plasmid that carried no coat sequence. Second, an inducible plasmid
that carried wild-type coat protein was co-expressed with a non-inducible plasmid that
carried no coat information. In each case, it was anticipated that VLPs would be formed
and that a baseline for their electrophoretic mobility in an agarose gel assay would be
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established. These two control conditions would be key as we expected that the net
charge associated with Flag would impart a different electrophoretic mobility to mosaic
VLPs as compared to either of these control conditions. Thus, we would know
immediately by a mobility shift if mosaic capsids were being generated. Table IX
highlights all co-expression experiments and associated control conditions.
To test for electrophoretic mobility, agarose gel electrophoresis was performed.
Individual white clones were selected from each experimental test condition and
subjected to analysis. Five co-expression test cases yielded VLPs (Figure 14). Three of
these cases were representative of a control condition in which wild-type coat protein was
generated. The other two test cases represented the heart of this co-expression
experiment. Co-expression of a wild-type coat with an inducible Flag fusion
(CT119dl5n/pAFCT) generated a VLP as per capsid gel analysis. However, its mobility
in the gel did not differ from that of wild-type coat protein essentially generated via three
different means (Figure 14). Co-expression of a non-inducible Flag fusion coat with an
inducible wild-type coat protein generated a capsid as well (pFCT/pACT119dl5n).
However, its mobility in agarose differed significantly from that of baseline wild-type
coat protein (Figure 14). In the other remaining test cases where Flag fusions were
expressed in the absence of wild-type coat or expressed via both plasmids, capsid gels
failed to demonstrate the presence of VLPs.
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F igure 13. N-terminal F lag insertions
Plasmid pCT119DL5N is similar to the previously described pCT119[11, 14], except for
NcoI site that also incorporates the coat protein initiation codon (delineated by arrow).
This plasmid expresses coat protein from the lac promoter. Plasmid pACTdl5n, a
pACYC-derived plasmid, expresses coat from the T7 promoter. Black boxes represent
the Flag insertions made in each plasmid configuration.
T able X . Co-expression partners for mosaic V L Ps
Non-induced plasmids are under the control of the lac promoter. Inducible plasmids are
under the control of the t7 promoter. In each case, a non-inducible plasmid and inducible
plasmid are co-transformed into E. coli and grown. Colonies were picked and cultured in
LB media with chloramphenicol and ampicillin to mid-log phase. IPTG was then added
and cultures were grown for an additional 3 hours. Cultures were then pelleted and
subjected to a capsid gel protocol. pUC and pACET are control plasmids that do not
generate coat protein.
T able X . M atrix of co-expression partners generated in this experiment.
Inducible
pACET
pACTdl5n
pAFCT
Non-inducible
pUC
X
X
X
pCT119dl5n
X
X
X
pFCT
X
X
X

Once ethidium bromide staining was completed, the gels were then employed via
nitrocellulose transfer to generate Western blots. Again, Western blots detect the
presence of coat protein and this information can be correlated with ethidium staining to
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establish the presence or absence of VLPs. Western blot analysis confirmed the presence
of MS2 protein in the same 5 co-expression test cases. In the co-expression test case
pFCT/pACTdl5n, we see the blot reflects the mobility shift of a VLP that apparently
incorporates both coat proteins (Figure 26, right panel). In a final step, a low-melt
agarose gel was run for all generated proteins (Figure 26). In this gel, bands
demonstrating positive ethidium bromide staining and correlating to the original bands in
the agarose gel were excised. These recovered bands were then slowly melted and
subjected to SDS-polyacrylamide electrophoresis. Results indicated the production of
wild-type coat protein in all lanes. In the lanes with two bands, the Western blot reflects
the incorporation of two proteins, presumably the ones of interest.

F igure 14. C haracterizing mosaic virus-like particles
(a) Agarose gel electrophoresis assay (capsid gel) and Western blot of co-expression
partners in approach to generate mosaic capsids. Given that VLPs contain RNA, they are
readily visualized with ethidium bromide (left panel). In Western blot, coat protein was
visualized using anti-MS2 anti-serum (right panel). (b) SDS-polyacrylamide gel
electrophoresis and Western blot analysis of proteins produced by co-expression
experiments. Proteins were visualized using anti-MS2 anti-serum. pUC and pACET are
control plasmids that do not generate coat protein. The bottom bands reflect expression of
wild-type coat protein. In the lane with two bands, the top band reflects the production of
Flag fused to coat protein.
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A ttempts to M aximize Tolerance of N-terminal F usions By Randomizing B racket
Sequences
Random inserts at the N-terminus of MS2 are highly destabilizing. In the body of
this research effort, several attempts have been employed to stabilize these insertions and
allow for eventual VLP formation. One approach that included the use of flanking serines
has, thus far, offered the greatest opportunity for VLP assembly. As this approach was a
direct attempt to resolve folding failures, a simplified, subtler hypothesis emerged to
address the same protein-folding problem. In this new approach, a sequence known to
result in a folding failure at the N-terminus was flanked by two randomized amino acid
positions. By doing so it was expected that Nature (natural selection) would provide a
more optimized solution for generating N-terminal MS2 recombinants. The choice of
having two randomized positions was based on the same serine study in which flanking
serines significantly improved n-terminal insertions. As an additional part of this serine
study, the configuration of serines that flanked a randomized sequence was incrementally
changed. In this extended effort, it was shown that by simply removing serines either
upstream or downstream of a randomized insert resulted in changes to overall folding or
assembly behavior. With this information in hand, it became clear that the two serines
located on either side of a randomized sequence offered significant benefits. Thus, in the
present effort, it was hypothesized that two randomized positions offered the greatest
potential benefit in yielding new N-terminal recombinants.
In order to facilitate N-terminal incorporation of this specialized peptide, a
plasmid, pCT119dl5n, was constructed from pCT119 as previously described [11, 14].
We then used a PCR primer encoding the known ten amino acid sequence flanked by two
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randomizing amino acid locations to generate a recombinant coat sequence. This
produced the resulting plasmid, pCT119dl5n- (NNY)2 ±(LNLVFILLSG)-(NNY)2. The
NNY triplet (N= any nucleotide, Y= T or C) was utilized to generate the two randomized
amino acid locations that flanked the intervening known peptide region because it
produces 15 out of the 20 standard amino acids. Although Met, Gln, Trp, Lys, or Glu are
not produced in NNY libraries, this approach avoided the incorporation of stop codons
and consequently limited the inclusion of truncated sequences in downstream analyses.
As initial efforts began to progress, it became clear that this plasmid configuration
was generating an unacceptably high background of non-recombinant clones. When
creating a vector for ligation of oligonucleotide products, there inevitably remains some
uncut plasmid even after restriction digest. We suspected that this was the source of the
high background of non-recombinant clones. Under normal conditions, the relatively low
background would be experimentally acceptable. However, even under increased
restriction endonuclease conditions, non-recombinants clones dominated experimental
recovery. We then decided that an new approach would be required in which the PCR
products generated with pCT119dl5n would be carefully re-separated via gel
electrophoresis. Next, the resulting product would be transferred into a new plasmid that
limited the potential to propagate non-recombinant clones forward.
To aid in this specialized peptide insertion, we utilized another previously
described plasmid pP7K [48]. This plasmid generates the coat for Pseudomonas phage
pP7. As we were trying to isolate very rare natural selection events, it was important to
efficiently identify colonies that contained our insertion of interest. pP7K under normal
conditional generates blue colonies in a coat repression assay designed for MS2. We,
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therefore, digested pP7K with SapI and Bam HI. In a three-part ligation, we then digested
the recovered PCR fragments with HindIII. As we still required a SapI-HindIII fragment,
we digested pCT119dl5N with SapI and HindIII to generate the final required fragment.
The two insert fragments were ligated with the pP7K vector and transformed into strain
CSH41F- containing plasmid pRZ5 and plated on LB medium. Although this step
seemed trivial, we felt the step necessary as we were trying to isolate what we believed to
be statistically hyper-infrequent randomization events. The resulting plasmid, pP7K(NNY)2 ±(LNLVFILLSG)-(NNY)2, was then utilized to generate additional n-terminal
recombinant proteins. Repression analysis yielded 6 potential clones capable of
generating fold-competent recombinant coat proteins. These six clones were then
subjected to sequence analysis to verify their coat constructions. The resulting data
indicated that all clones either contained frameshift mutations or had other ligation errors.
This entire experiment was repeated with no functional clones ever being recovered.
Thus, no recombinants clones with randomized brackets were generated in the monomer
configuration.
Insertion of Fusion Sequence into the Single-C hain Dimer
Attempts to generate recombinant proteins with randomized flanking sequences
failed in the monomer configuration. We then constructed a new plasmid incorporating
the single-chain dimer to express our randomizing specialized peptide. As illustrated by
the results, recombinant proteins with the correct genetic sequence were generated (Table
XI).
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MS2 Recombinant V L P Formation
A key outcome of this experimental effort was the expectation that the
introduction of N-terminal extensions would not prevent VLP assembly. When a capsid
gel was performed for the recovered sequences, no VLPs were visualized via ethidium
bromide staining. The control, p2CT119dl5N (p2M), generates a single-chain dimer of
the wild-type MS2 coat sequence. The presence of p2M was verified in the positive
control lane via ethidium bromide staining. To complete the experiment, a Western blot
was performed. However, as demonstrated by capsid gel, no recombinant VLPs were
generated.

F igure 15. Randomized brackets in N-terminus of MS2
(a) Arrangements of the coat protein reading frames on the plasmids used in this
experiment. Plasmid pCT119DL5N is similar to the previously described pCT119 [11,
14], except for NcoI site that also incorporates the coat protein initiation codon
(delineated by arrow). Plasmid p2CT119DL5N expresses a single-chain dimer version of
the protein. Black boxes represent the peptide insertions made in each plasmid
configuration. (b) Codons of the oligonucleotides utilized to make insertions in each
plasmid configuration.
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T able X I. Summary of randomized bracket configurations
White colonies, as they repress translation were the primary intent of this effort. Blue
colonies, were included to expand the data set on randomized brackets and the functional
behavior they imparted. Blue colonies were recovered from the original experiment in
which a high background of non-recombinants was generated.
T able X I. Summary of recombinant proteins expressed in this effort
Sample
NNY
N N Y2
K now Seq
N N Y3
WHITE
F1
Ser
Pro
LNLVFILLSG
Ser
F6
Asn
Tyr
LNLVFILLSG
His
F7
His
Ser
LNLVFILLSG
Ile
F8
Arg
Asn
LNLVFILLSG
Asn
F9
His
Asp
LNLVFILLSG
Ser
F11
Tyr
Tyr
LNLVFILLSG
Asn
BLUE
F2
Asp
Asp
LNLVFILLSG
His
F4
Asp
Asn
LNLVFILLSG
Asp
F10
Ile
Asp
LNLVFILLSG
Asp
F13
Asn
Asp
LNLVFILLSG
Asp
F14
Asp
Asn
LNLVFILLSG
Ser

N N Y4
Leu
Ser
Thr
His
Arg
Phe
Asn
His
Pro
Ser
Ser

F igure 16. V L P formation in randomized bracket configu ration
Electrophoresis on agarose gel of VLPs identified in lysates of cells producing
recombinant coat proteins. The first two lanes of each gel are controls: pCT119 produces
wild-type coat, while pUC productes no coat protein. An Ethidium bromide-stained gel
(top panel) and western blot probed with MS2 anti-serum (bottom panel) for
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recombinants are shown. Red boxes highlight control coat protein (p2M). Plasmid p2M
generates a single-chain wild-type coat protein.

67

  

D ISC USSI O N
N-T erminal Fusions
Since the N-terminus resides near the surface of the MS2 capsid, it represented a
potential location for peptide display. Initial efforts suggested that 10-amino acid Nterminal fusions were highly destabilizing. Even in the single-chain dimer random Nterminal fusions generated an unacceptably low number of functional VLPs. A review of
the literature identified several opportunities to further stabilize peptide stretches as they
were incorporated. The first approach suggested that the incorporation of glutamate or
aspartate sequences would introduce localized acidity around a peptide insertion, thereby
changing overall insertion hydrophobicity [9]. In the monomer configuration, only 2% of
random insertions yielded functional translational repressors. After the addition of
glutamate and aspartate brackets, the numbers improved to 65% and 79%. With these
acidic additions, however, VLP formation was still essentially zero.
As the data showed, incorporation of the single-chain dimer produced only 2%
functional repressors. Once acidic brackets were incorporated along with the singlechain dimer, functional repressors again increased to 79% for aspartate and 88% for
glutamate. However, even with the incorporation of the single-chain dimer and acidic
brackets, VLP formation improved to only 4%. What is clear, however, is that acidic
brackets do have the ability to minimize disruption to coat function upon peptide
insertion. Clearly, proper coat folding is the critical first step in VLP formation.
However, as implied by Billaud et al., acidic brackets alone will not fully stabilize protein
insertions. In the same study by Billaud, C-terminal modifications were also required to
allow for recombinant peptides to be displayed in a VLP. Perhaps acidic brackets, in
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concert with other modifications to MS2 coat, could allow for a high degree of VLP
display. But as it stands now, acidic brackets do not represent an ideal configuration for
N-terminal VLP display in MS2.
A second approach identified to potentially provide coat protein stability related
to the inclusion of flanking arginines. The premise behind this approach was that
flanking arginines would allow for the recruitment of chaperones and allow for refractory
peptide incorporation.

As a technical approach, similar efforts have been executed with

some success in filamentous phage [28, 34]. In the monomer configuration, random
insertions flanked by arginines yielded 58% functional repressors. VLP formation for
this configuration was zero. As efforts then transitioned into the single-chain dimer,
flanking arginine sequences yielded 95% functional recombinant repressors ± an
experimental high for all engineering modifications. VLP formation, however, remained
unchanged at zero. Again, as in the case of acidic brackets, coat function was
significantly restored with the addition of arginines. But, VLP formation, a critical goal
for this effort showed no improvement.
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F igure 17. A mino acid propensities
Summary of amino acid propensities at the boundaries of a E-Sheet and D-helix. Amino
acids listed here formed the basis for flanking sequences employed to stabilize foreign
peptide insertions.

The final approach offered in this experimental effort to correct folding failures in
MS2 coat was the implementation of amino acid propensities to predict optimum capping
residues for recombinant sequences. Although several amino acid combinations were
tried, flanking serines emerged as the best approach to stabilize random N-terminal
fusions. In the context of the monomer, flanking serines improved the fraction of
recombinants producing functional repressors from 2% to 70%. VLP formation, however,
improved only marginally to 4%. Once the single-chain dimer and flanking serines were
incorporated with random sequences, repressor function improved to 90-98% (corrected
for frameshift errors). Of these functional repressors, 100% also produced VLPs. Thus,
we have established a potentially significant role for serines in stabilizing recombinant
insertions at the N-terminus of MS2.
The increased stability that serines provide may offer another general approach to
stabilizing recombinant proteins. The importance of the single-chain dimer for the
success of VLP display applications is now well documented [11-13, 49]. In the several
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cases presented here, the incorporation of certain amino acid bracket sequences stabilized
the folded structure of MS2 coat. As serine emerged as being able to stabilize MS2 coat
and allow for VLP formation, we speculated if another, simpler mechanism could
account for the stabilizing effects observed for glutamate, aspartate, arginine, and serine.
Protein folding has, until relatively recently, relied heavily on statistical models that
describe secondary structures only in the context of helices and sheets. However, other
research efforts have extended secondary structure prediction to include intra-residue,
inter-residue, side-chain conformations, and related protein contacts in their models [5054].
Of particular note, are the hydrogen bonding interactions that can occur between
amino acid residues in polypeptides. In the case of arginine, it has been suggested that
because of the guanidinium group at the end of its chain, this amino acid, in particular,
has significant H-bonding potential [55]. In this same review by Borders et al., it was
highlighted that the guanidinium group of arginine has the ability to donate up to 5
hydrogen bonds to interact with peptide carbonyl atoms. This interaction of arginine with
the peptide backbone was thought to stabilize and maintain correct protein folding [55,
56]. In another article, it was suggested that small polar residues like serine posses the
ability to compensate for peptide backbone distortions because of their ability to form
compensating hydrogen bond interactions [51]. The implication here was that as random
insertions perturb the polypeptide backbone of MS2 coat, serine might minimize these
distortions through offsetting, non-standard H-bonds.
In the final case of charged amino acids like glutamate and aspartate, structural
polypeptide stabilization may be achieved by similar means. Glutamate has been shown
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to interact with its own backbone amide via the H-carbonyl oxygen in its side chain as
well as interacting with main-chain atoms upstream and downstream to its relative
polypeptide position [53]. Aspartate also interacts with main-chain atoms upstream and
downstream to its relative position. However, aspartate and its ability to h-bond to mainchain atoms 2 positions downstream of its location offers a unique side-chain/main-chain
FRQIRUPDWLRQ7KLVW\SHRIFRQIRUPDWLRQPLPLFVWKHW\SH,,¶E-turn and has been shown
to stabilize other E-turns [57]. Additionally, this unique conformation for aspartate has
been identified as critical in the propagation of some D-helices [15, 57]. Thus, for
arginine, serine, glutamate, and aspartate, it becomes clear that an alternate hypothesis of
simply side-chain/main-chain stabilization could be offered to explain the positive effects
uncovered in this study.
Although hydrophobicity, amino acid propensities, and molecular chaperone
recruitment represented the initial approaches identified to resolve folding failures in
MS2, a new, more simplified approach has also emerged. This modified approach simply
relates to protein stabilization. The increased stabilization offered from each technical
approach presented in this study does stand on its own merits. But, when you consider
protein folding in its most generic context, it becomes clear that the path to protein
stability can take many routes. In the case of MS2 coat protein, the use of the singlechain dimer represented but one path to coat protein stability.
In fact, it has been suggested that another equally viable approach to revert
folding defects could simply be to identify mutations at other sites in MS2 coat that
suppress effects introduced with the incorporation of recombinant sequences [13]. Thus,
protein contacts, side-chain interactions, hydrophobicity, backbone mimics, amino acid
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position, conformational geometries, etc., all represent technical approaches to be
considered in evaluating protein folding. Thus, as long as any technical approach to
protein folding considers its relative contribution to protein stability, it can only serve to
further expand our understanding of protein folding.
In the context of the present study, our primary goal was to identify opportunities
that allowed for the effective insertion of small peptides at the N-terminus of MS2 for
VLP display. With the identification of serines and the use of the single-chain dimer, we
have identified a system of modifications that correct most folding and assembly errors at
the N-terminus of MS2. Additionally, having a second insertion location in MS2 VLPs
for peptide display could prove to be very beneficial in targeted immunological
applications. First, one recombinant site on MS2 (n-terminus) could be employed for
cellular targeting, while the other site (AB-loop) could be allowed to locally induce the
immune response [12, 58]. This could potentially offer a highly specific immunological
approach to deal with disease. Second, the N-terminus represents an opportunity where
peptides can be presented in an un-constrained fashion ± which has been suggested as
another, but less effective means of generating biologically relevant three-dimensional
targets for antibodies [59]. Thus, VLPs generated by randomized insertions at the Nterminus should expand libraries constructed to identify epitopes in immunological
applications and increase the utility of the MS2 platform for other biotechnology
applications.
A B-Loop Insertions
The AB-loop, as it resides near the surface of the MS2 capsid, has recently
become a target for peptide display. Initial efforts suggested that peptide insertions at the
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AB-loop were highly destabilizing. In our original technical approach, we expected that
the stabilizing effects of the single-chain dimer would restore folding in recombinant ABloop coat sequences. As the single-chain dimer is essentially comprised of two coat
protein monomers, two AB-loop targets become available for insertion in this
configuration. In the research activities that followed, it was shown that peptides could
EHGLVSOD\HGLQGRZQVWUHDP ¶ $%-loop via this specialized coat construction [12].
+RZHYHULWZDVDOVRFOHDUWKDWWKHXSVWUHDPRU¶$%-loop was refractory to insertion
under most conditions. A review of the literature outlined several opportunities to
SRWHQWLDOO\VWDELOL]HSHSWLGHVWUHWFKHVDVWKH\ZHUHLQFRUSRUDWHGLQWKH¶ORRS:H
identified two approaches that follow: one in which amino acid sequences were shown to
cap or essentially provide termination of secondary structures; and two, the potential
recruitment of molecular chaperones via specialized amino acid sequences.
Our first approach related to the inclusion of flanking arginines. The thought
behind this methodology was that flanking arginines would recruit chaperones to the ABloop capable of assisting in refractory peptide insertion. Similar approaches have been
attempted with some success in filamentous phage [28, 34]. In the monomer
configuration, random insertions flanked by arginines produced only 2% functional
repressors. However, once focus shifted to the single-chain dimer, flanking arginine
sequences yielded 71% for twin flanking arginines and 86% functional recombinant
repressors for quad flanking arginines ± an experimental high for all engineering
modifications. VLP formation, however, only improved to 17% for twin arginines and
8% for quad flanking arginines. What is clear, though, was that coat repressor function
was significantly restored with the addition of arginines.
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As the data outlined, incorporation of the single-chain dimer alone produced 41%
IXQFWLRQDOUHSUHVVRUVLQWKH¶$%-loop. VLP formation in the insert-only configuration
was at 42%. For immunological activities planned in the future, having low effective
insert frequencies and low particle formation would be technically unacceptable. Once
capping sequences, our second approach, were incorporated along with the single-chain
dimer, functional repressors increased to a high of 80% for serines. Additionally, VLP
formation for serine capped sequences, improved to 75% VLP formation.
Although sequences capped by aspartate showed a 40% improvement in VLP
formation, this result was not above that of the baseline, single-chain dimer
configuration. However, given that aspartate produced 74% functional repressors, it was
clear that acidic brackets do have the ability to minimize disruption to coat function upon
peptide insertion. As suggested by Billaud et al., acidic brackets alone will not fully
stabilize protein insertions. Other polypeptide changes including C-terminal
modifications were needed to allow for recombinant peptides to be displayed in a VLP.
Perhaps other offsetting modifications to MS2 coat, as suggested by other research efforts
will allow for a high degree of VLP display [13]. But as it stands now, acidic brackets do
not represent an ideal engineering moGLILFDWLRQWRDOORZIRU¶$%-loop peptide insertions
and eventual VLP display.
The increased stability that serines provide may again offer the best technical
solution to stabilizing recombinant proteins in this application. In this effort, we have
shown that the use of certain di-peptide brackets can stabilize the folded structure of MS2
coat. However, di-serine brackets proved the most efficient at suppressing both coat
protein folding and VLP assembly defects. As we considered how terminal serines
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benefitted AB-loop insertions, we tried to identify an underlying mechanism. To get at
this problem, we reviewed other technical literature that described efforts to expand
secondary structure prediction. As a result, we identified several technical approaches
that put a new light on protein folding in general. These other approaches included intraresidue, inter-residue, side-chain conformations, and related protein contacts in their
models [50-54]. As noted with N-terminal insertions, hydrogen bonding emerged as the
consensus approach to best expand our understanding of how amino acids interact in the
context of a polypeptide chain.
Arginine, in and of itself, offers a very complex network of H-bonding
interactions. The guanidinium group at the end of its chain has the potential to provide
up to 5 hydrogen bonds as its side chain interacts with the main polypeptide chain and
other amino acids [55]. Serine, which was found to offer the greatest ability to stabilize
AB-ORRSLQVHUWLRQVLQWKH¶GLPHUDQGSURPRWH9/3IRUPDWLRQDOVRSRVVHVVHVDJUHDW
ability to promote hydrogen interactions during protein formation. In fact, serine was
identified it as having a unique capacity to compensate for peptide backbone distortions
[51]. Mechanistically, serine could work to stabilize AB-loop insertions through intra- or
inter-strand h-bonds. In the final case of a charged amino acid like aspartate, H-bonding
appeared once again to be able to account for the stabilization offered by this amino acid
residue. Aspartate possesses the ability to cooperate with main-chain atoms upstream
and downstream to its relative position. Aspartate makes one particular conformation
ZKLFKLVWKRXJKWRPLPLFWKHW\SH,,¶E-turn, stabilize other E-turns, and even potentially
nucleate to formation of some D-helices [15, 57]. Hence, the effects of arginine, serine,
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and aspartate demonstrated in this study can all otherwise be defined by the stabilizing
interactions between side-chains and main-chains.
Although E-sheet capping interactions and molecular chaperone recruitment were
the initial approaches taken to address AB-loop failures in MS2, a new, more simplified
approach has emerged. Proteins clearly can be stabilized by novel protein interactions
introduced with the strategic placement of amino acids. The increased stabilization
offered from each technical approach presented in this study highlights how H-bonding
can be applied to stabilize a recombinant protein. In the case of MS2 coat protein, the
use of the single-chain dimer represents but one path to coat protein stability. Protein
contacts, side-chain interactions, hydrophobicity, backbone mimics, amino acid position,
conformational geometries, etc., also offer the potential of equal validity in addressing
folding failures identified in this effort.
In the context of the present study, our primary goal was to identify opportunities
that allowed for the effective insertion RIVPDOOSHSWLGHVLQWKH¶$%-loop of MS2 for
VLP display. With the identification of terminal serines and the use of the single-chain
dimer, we have identified a system of modifications that corrects a significant percentage
of folding and assembly erroUVLQWKH¶$%-loop. Additionally, we have made available
a second loop insertion location in MS2 VLPs. We believe that this additional site could
prove to be very beneficial in targeted immunological applications. First, having two
identical sites to display an epitope has the potential to induce maximum immunogenicity
± as it increases the density of antigens available to activate the immune system [12, 60].
Second, having an additional site could allow for multiple epitope presentation on the
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same particle. As the flu vaccine is designed to provide a spectrum of viral epitopes for
immunization, having multiple sites for antigen presentation could offer a similar benefit.
$VSDUWRIWKLVHIIRUWZHDOVRFRQVLGHUHGWKHW\SHRISHSWLGHVQRWWROHUDWHGLQWKH¶
loop and sought to identify any obvious trends that emerged from their analysis. For
example, it had already been demonstrated that peptide sequences that were refractory in
WKH¶ORRSDSSHDUHGWREHKLJKO\HQULFKHGLQK\GURSKRELFVHTXHQFHV[12]. In the case of
WKH¶ORRSZHGRQRWVHHWKHVDPHSKHQRPHQD2QDUHODWHGFRQFHUQZHDOVR
investigated the potential of amino acids to impart localized constraints through the
introduction of novel secondary structures. Therefore, we chose to look at all sequences
WKDWZHUHDFFRPPRGDWHGRUZHUHUHIUDFWRU\LQWKH¶ORRSDQGPRGHOHGWKHLUSURSHQVLW\
to form sheets or helices. In conclusion, we identified engineering modifications that
DOORZHGIRULQFUHDVHGGLVSOD\RIUHFRPELQDQWSHSWLGHVLQWKH¶$%-loop of the singlechain dimer. With this new display site in hand, MS2 VLPs should provide the means to
identify peptides with novel immunological properties and allow for their display as part
of an expanded vaccine platform.
O ther A pproaches to N-terminal Peptide Display
The N-terminus, as it resides near the surface of the MS2 capsid, offers the
potential to be utilized in the display of peptides. Initial efforts suggested that, without
extensive engineering, viable insertions at the N-terminus would be extremely rare. To
correct for potential folding failures, we planned to implement the incorporation of the
single-chain dimer. Our expectation was, as in other phage display efforts, that the single
chain dimer would offer additional stability necessary to revert the folding defects that
we had encountered [11, 12, 61]. However, the addition of the single-chain dimer proved
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to not be the optimum solution that we required. Thus, we went back to the literature and
identified two potential enhancements that we felt, in concert with the single-chain dimer,
would provide the solution we needed. The first approach involved the co-expression of a
wild-type coat sequence with a recombinant coat sequence in the hopes of generating a
mosaic capsid.
To execute this study, we drew from an earlier effort in which attempts had been
made to attach the Flag peptide to the N-terminus of MS2. In this study, the Flag peptide
could only be expressed in a virus-like particle with the help of the single-chain dimer.
In our new approach, we recognized that Flag incorporation into the monomer
configuration actually produced a properly folded, repressor-competent protein. This
idea of a properly folded protein was key. Although Flag recombinant proteins failed to
assemble into a VLP, its properly folded configuration could allow for its incorporation
with wild-type coat sequences.
As anticipated, the monomer configuration with Flag was successfully
incorporated into a mosaic VLP. We believe this effort succeeded because the flexibility
of the wild-type coat sequence offered the greatest opportunity to incorporate a
recombinant protein that may have lost some of its own conformational flexibility. We
base our conclusion on the fact that we knew that the wild-type coat protein in the
assembly of the native MS2 particle assumed three different conformations to generate a
capsid. Thus, native FRDWSURWHLQ¶VIOH[LELOLW\FRXOGRIIHUDQDVVHPEO\DGYDQWDJH
The requirement for a properly folded recombinant protein came from another
effort to incorporate improperly folded recombinant proteins into mosaic capsids. In
those efforts, we failed to identify any improperly folded proteins capable of
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incorporation into a mosaic particle (unpublished results). However, in the case of the
Flag fusion construct, this peptide was capable of acting as a functional repressor ±which
suggests it being properly folded. As a result, Flag fusions with the addition of a wildtype coat sequences were efficiently incorporated into a VLP. The only challenge that
remains with this approach for future efforts is to ensure that the RNA sequence that
encodes for the recombinant protein is efficiently incorporated into the mosaic capsid.
But, this approach may prove to be viable in instances where a know sequence remains
refractory to VLP display and needs to be incorporated into a mosaic capsid to determine
its interaction with other proteins.
In our second approach to incorporate sequences at the N-terminus, we sought to
randomize two amino acid locations around a known refractory sequence. We believed
that this would introduce sequences that stabilized the overall recombinant coat sequence.
As the data showed, this approach was capable of producing functional repressors as long
as the single-chain dimer was part of the technical approach. However, none of the
identified pairs of amino acids yielded VLPs. As we were able to show in another study,
two serines flanking a randomized peptide insert generated function repressors and VLPs.
As we worked to identify a mechanism to explain the phenomena of serines, we found
that this amino acid, in particular, offered incredible conformational flexibility. In fact,
the increased stability that serines provided may offer another general approach to
stabilizing recombinant proteins.
At this point, we believe that serine offers the ability to form intra- and interstrand hydrogen bonds. As we identified in a second study on the beneficial aspects of
serine, we noted that both positions that flanked a randomized sequence were required to
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generate a VLP. In our case of randomized locations, we identified several amino acid
combinations that allowed for dimer stabilization. However, none of the conformations
identified were able to nucleate assembly. Protein folding continues to be one of the most
complex issues faced by scientists. Mosaic particle formation, strategic incorporation of
stabilizing amino acids, single-chain dimer construction ± all represent new tools to aid in
the development of an optimum platform for phage display. Both strategies presented
herein provide additional opportunities to aid in the creation and identification of novel
peptides. As we come to better understand those factors that influence the nature of
protein folding, we will better be able to expand the de novo strategies available for
protein engineering. For the MS2 platform, having a repository of technical approaches
on which to generate VLPs will ensure platform complexity and allow for the flexibility
to address the challenges that lay ahead.

81

  

R E F E R E N C ES
1.
2.
3.
4.
5.
6.

7.

8.

9.
10.
11.
12.

13.
14.

15.
16.
17.

18.

Smith, G.P. and V.A. Petrenko, Phage Display. Chemical Reviews, 1997. 97(2):
p. 391-410.
Breitling, F., and Dübel, S., Recombinant Antibodies. 1999, New York: John
Wiley and Sons.
Kehoe, J.W. and B.K. Kay, F ilamentous Phage Display in the New Millennium.
Chemical Reviews, 2005. 105(11): p. 4056-4072.
Castagnoli, L., et al., Alternative Bacteriophage Display Systems. Combinatorial
Chemistry & High Throughput Screening, 2001. 4(2): p. 121.
Rothe, A., R.J. Hosse, and B.E. Power, In vitro display technologies reveal novel
biopharmaceutics. FASEB J., 2006. 20(10): p. 1599-1610.
He, M. and M.J. Taussig, Rapid discovery of protein interactions by cell-free
protein technologies. Biochemical Society Transactions, 2007. 035(5): p. 962965.
He, M. and M. Taussig, Antibody-ribosome-mRNA (ARM) complexes as efficient
selection particles for in vitro display and evolution of antibody combining sites.
Nucl. Acids Res., 1997. 25(24): p. 5132-5134.
+DQHV-DQG$3O¥FNWKXQ In vitro selection and evolution of functional
proteins by using ribosome display. Proceedings of the National Academy of
Sciences of the United States of America, 1997. 94(10): p. 4937-4942.
Billaud, J.-N., et al., Combinatorial Approach to Hepadnavirus-Like Particle
Vaccine Design. J. Virol., 2005. 79(21): p. 13656-13666.
Amstutz, P., et al., In vitro display technologies: novel developments and
applications. Current Opinion in Biotechnology, 2001. 12(4): p. 400-405.
Peabody, D.S., Subunit Fusion Confers Tolerance to Peptide Insertions in a Virus
Coat Protein. Archives of Biochemistry and Biophysics, 1997. 347(1): p. 85-92.
Peabody, D.S., et al., Immunogenic Display of Diverse Peptides on Virus-like
Particles of RNA Phage MS2. Journal of Molecular Biology, 2008. 380(1): p.
252-263.
Peabody, D., A Viral Platform for Chemical Modification and Multivalent
Display. Journal of Nanobiotechnology, 2003. 1(1): p. 5.
Peabody, D., Translational Repression by Bacteriophage MS2 Coat Protein
Expressed F rom a Plasm id: A System for Genetic Analysis of a Protein-RNA
Interaction. J Biol Chem, 1990. 265: p. 5684 - 5689.
Richardson, J. and D. Richardson, Amino acid preferences for specific locations
at the ends of alpha helices. Science, 1988. 240(4859): p. 1648-1652.
Presta, L.G. and G.D. Rose, Helix Signals in Proteins. Science, 1988. 240(4859):
p. 1632-1641.
Chakrabartty A et al., Helix capping propensities in peptide parallel those in
proteins. Proceedings of the National Academy of Sciences of the United States
of America, 1993. 90(23): p. 11332-11336.
Chou, P.Y. and G.D. Fasman, Conformational parameters for amino acids in
helical, beta-sheet, and random coil regions calculated from proteins.
Biochemistry, 1974. 13(2): p. 211-222.
82

  
19.
20.
21.

22.
23.

24.
25.

26.

27.

28.

29.
30.

31.

32.
33.

34.

Chou, P.Y. and G.D. Fasman, Prediction of protein conformation. Biochemistry,
1974. 13(2): p. 222-245.
Guzzo, A., The Influence of Amino Acid Sequence on Protein Structure.
Biophysical Journal, 1965. 5(6): p. 809-822.
Street, A.G. and S.L. Mayo, ,QWULQVLF¯-Sheet Propensities Result from van der
Waals Interactions between Side Chains and the Local Backbone. Proceedings of
the National Academy of Sciences of the United States of America, 1999. 96(16):
p. 9074-9076.
FarzadFard, F., et al., [beta]-Sheet capping: Signals that initiate and terminate
[beta]-sheet formation. Journal of Structural Biology, 2008. 161(1): p. 101-110.
Yawen Bai, S.W.E., Hydrogen bond strength and beta-sheet propensities: The
role of a side chain blocking effect. Proteins: Structure, Function, and Genetics,
1994. 18(3): p. 262-266.
Koh, E., T. Kim, and H.-s. Cho, Mean curvature as a major determinant of
{beta}-sheet propensity. Bioinformatics, 2006. 22(3): p. 297-302.
Chakrabartty, A., A.J. Doig, and R.L. Baldwin, Helix Capping Propensities in
Peptides Parallel Those in Proteins. Proceedings of the National Academy of
Sciences of the United States of America, 1993. 90(23): p. 11332-11336.
Koehl, P. and M. Levitt, Structure-Based Conformational Preferences of Amino
Acids. Proceedings of the National Academy of Sciences of the United States of
America, 1999. 96(22): p. 12524-12529.
Engel, D.E. and W.F. DeGrado, Amino Acid Propensities are Position-dependent
Throughout the Length of [alpha]-Helices. Journal of Molecular Biology, 2004.
337(5): p. 1195-1205.
Thammawong, P., et al., Twin-arginine signal peptide attributes effective display
of C D147 to filamentous phage. Applied Microbiology and Biotechnology, 2006.
69(6): p. 697-703.
Pugsley, A.P., The complete general secretory pathway in gram-negative
bacteria. Microbiol. Mol. Biol. Rev., 1993. 57(1): p. 50-108.
Schafer, U., K. Beck, and M. Muller, Skp, a Molecular Chaperone of Gramnegative Bacteria, Is Required for the Formation of Soluble Periplasmic
Intermediates of Outer Membrane Proteins. J. Biol. Chem., 1999. 274(35): p.
24567-24574.
Kuehn, M.J., S. Normark, and S.J. Hultgren, Immunoglobulin-like PapD
chaperone caps and uncaps interactive surfaces of nascently translocated pilus
subunits. Proceedings of the National Academy of Sciences of the United States
of America, 1991. 88(23): p. 10586-10590.
Saier, M., Protein Secretion and Membrane Insertion Systems in Gram-Negative
Bacteria. Journal of Membrane Biology, 2006. 214(1): p. 75-90.
Perez-RodrÌguez, R., et al., An Essential Role for the DnaK Molecular Chaperone
in Stabilizing Over-expressed Substrate Proteins of the Bacterial Twin-arginine
Translocation Pathway. Journal of Molecular Biology, 2007. 367(3): p. 715-730.
Paschke, 0DQG:+ÖKQH A twin-arginine translocation (Tat)-mediated phage
display system. Gene, 2005. 350(1): p. 79-88.

83

  
35.

36.

37.

38.

39.
40.
41.
42.
43.
44.
45.

46.

47.

48.

49.
50.
51.

Tapley, T.L., J.R. Cupp-Vickery, and L.E. Vickery, Sequence-Dependent Peptide
Binding Orientation by the Molecular Chaperone DnaK &#x2020. Biochemistry,
2005. 44(37): p. 12307-12315.
Crouy-Chanel, A.d., M. Kohiyama, and G. Richarme, Specificity of DnaK for
Arginine/Lysine and Effect of DnaJ on the Amino Acid Specificity of DnaK. J.
Biol. Chem., 1996. 271(26): p. 15486-15490.
Rudiger, S., et al., Substrate specificity of the DnaK chaperone deter mined by
screening cellulose-bound peptide libraries. The EMBO Journal, 1997. 16(7): p.
1501-1507.
Patrik Kasper, P.C., Heinz Gehring,, E mpirical calculation of the relative free
energies of peptide binding to the molecular chaperone DnaK. Proteins:
Structure, Function, and Genetics, 2000. 40(2): p. 185-192.
Smith, G.P., Preface. Gene, 1993. 128: p. 1-2.
McConnell, S.J., M.L. Kendall, et al. , Constrained peptide libraries as a tool for
finding mimotopes. Gene, 1994. 151: p. 115-8.
Mead, D.A., B. Kemper, Vectors: A survey of molecular cloning vectors and their
uses. Biotechnology (Reading, Mass), 1988. 10: p. 1-578.
Cesareni, G., Vectors: A survey of molecular cloning vectors and their uses.
Biotechnology (Reading, Mass), 1988. 10: p. 1-578.
Peabody, D. and F. Lim, Complementation of RNA binding site mutations in MS2
coat protein heterodimers. Nucleic Acids Res, 1996. 24: p. 2352 - 2359.
Peabody, D., The RNA-binding site of bacteriophage MS2 coat protein. EMBO J,
1993. 12: p. 595 - 600.
Burnette, W., ³:HVWHUQ%ORWWLQJ´(OHFWURSKRUHWLFWUDQVIHURISURWHLQVIURP
sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and
radiographic detection with antibody and radioiodinated protein A. Analytical
Biochemistry, 1981. 112(2): p. 195-203.
Gunasekaran, K., et al., Stereochemical punctuation marks in protein structures:
glycine and proline containing helix stop signals. Journal of Molecular Biology,
1998. 275(5): p. 917-932.
Stoycheva, A.D., C.L. Brooks Iii, and J.N. Onuchic, Gatekeepers in the
Ribosomal Protein S6: Thermodynamics, Kinetics, and Folding Pathways
Revealed by a Minimalist Protein Model. Journal of Molecular Biology, 2004.
340(3): p. 571-585.
Lim, F., T.P. Downey, and D.S. Peabody, Translational Repression and Specific
RNA Binding by the Coat Protein of the Pseudomonas Phage PP7. Journal of
Biological Chemistry, 2001. 276(25): p. 22507-22513.
Caldeira, J. and D. Peabody, Stability and assembly in vitro of bacteriophage PP7
virus-like particles. Journal of Nanobiotechnology, 2007. 5(1): p. 10.
Faure, G., A. Bornot, and A.G. de Brevern, Protein contacts, inter-residue
interactions and side-chain modelling. Biochimie, 2008. 90(4): p. 626-639.
Gunasekaran, K., C. Ramakrishnan, and P. Balaram, Disallowed Ramachandran
Conformations of Amino Acid Residues in Protein Structures. Journal of
Molecular Biology, 1996. 264(1): p. 191-198.

84

  
52.
53.

54.

55.
56.
57.

58.
59.

60.

61.

Doig, A.J. and M.J.E. Sternberg, Side-chain conformational entropy in protein
folding. Protein Science, 1995. 4(11): p. 2247-2251.
Eswar, N. and C. Ramakrishnan, Deterministic features of side-chain main-chain
hydrogen bonds in globular protein structures. Protein Eng., 2000. 13(4): p. 227238.
Stapley, B.J. and A.J. Doig, F ree energies of amino acid side-chain rotamers in
[alpha]-helices, [beta]-sheets and [alpha]-helix N-caps. Journal of Molecular
Biology, 1997. 272(3): p. 456-464.
Borders, C.L., et al., A structural role for arginine in proteins: Multiple hydrogen
bonds to backbone carbonyl oxygens. Protein Science, 1994. 3(4): p. 541-548.
White, S.H., Amino acid preferences of small proteins : Implications for protein
stability and evolution. Journal of Molecular Biology, 1992. 227(4): p. 991-995.
Eswar, N. and C. Ramakrishnan, Secondary structures without backbone: an
analysis of backbone mi micry by polar side chains in protein structures. Protein
Eng., 1999. 12(6): p. 447-455.
Morris, M.C., et al., Cell-penetrating peptides: from molecular mechanisms to
therapeutics. Biology of the Cell, 2008. 100(4): p. 201-217.
Herman, R.E., et al., The Trp Cage Motif as a Scaffold for the Display of a
Randomized Peptide Library on Bacteriophage T7. Journal of Biological
Chemistry, 2007. 282(13): p. 9813-9824.
Houten, N.E.V. and J.K. Scott, eds. Phage Libraries for Developing AntibodyTargeted Diagnostics and Vaccines. Phage Display in Biotechnology and Drug
Discovery, ed. S. Sidhu. 2005, CRC Press: Boca Raton. 165-254.
Liang, H., W.S. Sandberg, and T.C. Terwilliger, Genetic Fusion of Subunits of a
Dimeric Protein Substantially Enhances its Stability and Rate of Folding.
Proceedings of the National Academy of Sciences of the United States of
America, 1993. 90(15): p. 7010-7014.

85

